Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
GRNLSA.p53_damage: Meta traits — page 5
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 297 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 4,001–5,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 4001 | GGH levels | PROLV000882 | 0.01 | Protein levels | Hepatocyte | 79 | 3 | 11 | 22 | |
| 4002 | BRK1 levels | PROLV000213 | 0.01 | Protein levels | Vascular | 25 | 3 | 9 | 17 | |
| 4003 | Polycythaemia | HEMAT000012 | 0.01 | Hematologic | Vascular | 2 | 2 | 7 | 14 | |
| 4004 | IL15RA levels | PROLV001049 | 0.01 | Protein levels | Lymphocyte | 1 | 0 | 7 | 10 | |
| 4005 | Ankle spacing width | MSKEL000056 | 0.01 | Musculoskeletal | Stromal / connective | 338 | 2 | 5 | 6 | |
| 4006 | Eosinophil | HEMAT000030 | 0.01 | Hematologic | Lymphocyte | 1,935 | 2 | 16 | 25 | |
| 4007 | Thyroid disorder | ENDOC000023 | 0.01 | Endocrine | Lymphocyte | 189 | 1 | 10 | 25 | |
| 4008 | SHISA5 levels | PROLV001856 | 0.01 | Protein levels | Myeloid | 6 | 1 | 3 | 7 | |
| 4009 | FABP2 levels | PROLV000752 | 0.01 | Protein levels | Myeloid | 44 | 4 | 10 | 17 | |
| 4010 | HCLS1/LAT ratio | PRORT001274 | 0.01 | Protein ratios | Hepatocyte | 8 | 2 | 10 | 19 | |
| 4011 | CELSR2 levels | PROLV000398 | 0.01 | Protein levels | Muscle / cardiac | 14 | 2 | 9 | 15 | |
| 4012 | C2/LILRB4 ratio | PRORT000264 | 0.01 | Protein ratios | Myeloid | 71 | 3 | 11 | 24 | |
| 4013 | SH2D1A levels | PROLV001852 | 0.01 | Protein levels | Lymphocyte | 41 | 2 | 10 | 28 | |
| 4014 | CD207 levels | PROLV000318 | 0.01 | Protein levels | Myeloid | 130 | 2 | 6 | 11 | |
| 4015 | Nerve root and plexus disorder | NEURO000029 | 0.01 | Neurologic | Myeloid | 0 | 2 | 8 | 12 | |
| 4016 | LATS1 levels | PROLV001186 | 0.01 | Protein levels | Myeloid | 4 | 3 | 6 | 16 | |
| 4017 | UNC5D levels | PROLV002141 | 0.01 | Protein levels | Neural / glial | 0 | 1 | 7 | 30 | |
| 4018 | KIFBP/TBC1D23 ratio | PRORT001405 | 0.01 | Protein ratios | Muscle / cardiac | 3 | 4 | 10 | 24 | |
| 4019 | TNFRSF14/TNFSF14 ratio | PRORT001851 | 0.01 | Protein ratios | Hepatocyte | 14 | 3 | 15 | 47 | |
| 4020 | PRELP levels | PROLV001627 | 0.01 | Protein levels | Stromal / connective | 71 | 4 | 9 | 11 | |
| 4021 | Sulcal opening distance | NIMAG000012 | 0.01 | Neuroimaging | Vascular | 11 | 5 | 9 | 18 | |
| 4022 | Iron deficiency anaemia | HEMAT000011 | 0.01 | Hematologic | Hepatocyte | 16 | 1 | 3 | 9 | |
| 4023 | GPKOW/PXN ratio | PRORT001239 | 0.01 | Protein ratios | Myeloid | 0 | 1 | 5 | 9 | |
| 4024 | Keloid and scarring | DERMA000041 | 0.01 | Dermatologic | Muscle / cardiac | 17 | 2 | 3 | 19 | |
| 4025 | AGRP/NPY ratio | PRORT000050 | 0.01 | Protein ratios | Hepatocyte | 28 | 1 | 9 | 10 | |
| 4026 | CCN2/HBEGF ratio | PRORT000365 | 0.01 | Protein ratios | Myeloid | 66 | 3 | 14 | 13 | |
| 4027 | CD1C/CD207 ratio | PRORT000391 | 0.01 | Protein ratios | Myeloid | 46 | 3 | 9 | 13 | |
| 4028 | CEBPB/PXN ratio | PRORT000592 | 0.01 | Protein ratios | Neural / glial | 0 | 3 | 6 | 17 | |
| 4029 | Creatine metabolites | METAB000058 | 0.01 | Metabolites | Muscle / cardiac | 0 | 2 | 7 | 10 | |
| 4030 | DKK1/VTA1 ratio | PRORT000906 | 0.01 | Protein ratios | Myeloid | 1 | 3 | 14 | 24 | |
| 4031 | APPL2 levels | PROLV000130 | 0.01 | Protein levels | Stromal / connective | 3 | 2 | 5 | 8 | |
| 4032 | Viral seropositivity | IMMUN000078 | 0.01 | Immunologic | Hepatocyte | 0 | 1 | 6 | 22 | |
| 4033 | CALCOCO1/TBC1D5 ratio | PRORT000302 | 0.01 | Protein ratios | Neural / glial | 0 | 3 | 16 | 33 | |
| 4034 | Arrhythmia | CARDI000018 | 0.01 | Cardiac | Muscle / cardiac | 192 | 2 | 4 | 9 | |
| 4035 | Malocclusion | DENTA000008 | 9.99e-03 | Dental | Stromal / connective | 0 | 0 | 1 | 2 | |
| 4036 | CTSV levels | PROLV000569 | 9.98e-03 | Protein levels | Myeloid | 145 | 3 | 6 | 13 | |
| 4037 | AGER levels | PROLV000054 | 9.95e-03 | Protein levels | Vascular | 97 | 1 | 7 | 11 | |
| 4038 | Eye disorder | OPHTH000008 | 9.91e-03 | Ophthalmic | Neural / glial | 4 | 1 | 1 | 7 | |
| 4039 | PGLS levels | PROLV001545 | 9.86e-03 | Protein levels | Neural / glial | 0 | 5 | 6 | 27 | |
| 4040 | Gastric ulcer | GASTR000048 | 9.66e-03 | Gastrointestinal | Lymphocyte | 3 | 1 | 7 | 27 | |
| 4041 | TDGF1 levels | PROLV002006 | 9.60e-03 | Protein levels | Myeloid | 46 | 2 | 2 | 5 | |
| 4042 | IFIT3 levels | PROLV001017 | 9.55e-03 | Protein levels | Stromal / connective | 0 | 2 | 5 | 12 | |
| 4043 | CALCOCO1/MAP3K5 ratio | PRORT000298 | 9.54e-03 | Protein ratios | B / plasma cell | 0 | 4 | 13 | 30 | |
| 4044 | FUCA1 levels | PROLV000833 | 9.48e-03 | Protein levels | Hepatocyte | 40 | 2 | 10 | 18 | |
| 4045 | ASAH1 levels | PROLV000149 | 9.47e-03 | Protein levels | Myeloid | 48 | 6 | 13 | 26 | |
| 4046 | Progesterone metabolite | METAB000072 | 9.42e-03 | Metabolites | Hepatocyte | 13 | 1 | 6 | 18 | |
| 4047 | Cholecystitis | HPBIL000008 | 9.33e-03 | Hepatopancreatobiliary | Hepatocyte | 18 | 2 | 7 | 7 | |
| 4048 | HMOX2 levels | PROLV000979 | 9.30e-03 | Protein levels | Muscle / cardiac | 52 | 2 | 7 | 13 | |
| 4049 | Family history, breast cancer | MALIG000038 | 9.16e-03 | Malignancy | Myeloid | 0 | 1 | 4 | 8 | |
| 4050 | HDGF levels | PROLV000959 | 9.13e-03 | Protein levels | Myeloid | 18 | 3 | 7 | 12 | |
| 4051 | GSTT2 levels | PROLV000942 | 9.11e-03 | Protein levels | Gastrointestinal epithelium | 0 | 0 | 7 | 8 | |
| 4052 | ELOA/MAD1L1 ratio | PRORT001015 | 9.05e-03 | Protein ratios | Myeloid | 4 | 3 | 9 | 15 | |
| 4053 | Pain, neck | MSKEL000040 | 9.04e-03 | Musculoskeletal | Neural / glial | 3 | 3 | 16 | 34 | |
| 4054 | PROK2 levels | PROLV001639 | 8.97e-03 | Protein levels | Hepatocyte | 4 | 4 | 9 | 11 | |
| 4055 | PDIA4 levels | PROLV001527 | 8.96e-03 | Protein levels | Stromal / connective | 5 | 2 | 5 | 12 | |
| 4056 | NTF3 levels | PROLV001442 | 8.92e-03 | Protein levels | Vascular | 1 | 3 | 8 | 14 | |
| 4057 | CD101 levels | PROLV000308 | 8.76e-03 | Protein levels | Lymphocyte | 57 | 2 | 17 | 43 | |
| 4058 | SIT1 levels | PROLV001871 | 8.72e-03 | Protein levels | Lymphocyte | 69 | 2 | 16 | 32 | |
| 4059 | ST6GAL1 levels | PROLV001953 | 8.55e-03 | Protein levels | Myeloid | 81 | 3 | 11 | 16 | |
| 4060 | HAVCR1 levels | PROLV000953 | 8.49e-03 | Protein levels | Hepatocyte | 20 | 0 | 8 | 27 | |
| 4061 | Peripheral nerve disorder | NEURO000031 | 8.45e-03 | Neurologic | Stromal / connective | 5 | 2 | 5 | 10 | |
| 4062 | Cervical intraepithelial lesion | REPRO000002 | 8.36e-03 | Reproductive | Lymphocyte | 23 | 2 | 11 | 25 | |
| 4063 | Medication, ACE inhibitor | VASCU000028 | 8.35e-03 | Vascular | Vascular | 12 | 0 | 2 | 3 | |
| 4064 | MMP8/TGFA ratio | PRORT001545 | 8.34e-03 | Protein ratios | Myeloid | 0 | 1 | 8 | 8 | |
| 4065 | DNPH1/PDGFB ratio | PRORT000936 | 8.34e-03 | Protein ratios | Hepatocyte | 5 | 4 | 7 | 23 | |
| 4066 | C1QTNF1 levels | PROLV000224 | 8.32e-03 | Protein levels | Neural / glial | 27 | 2 | 10 | 34 | |
| 4067 | AIF1 levels | PROLV000068 | 8.20e-03 | Protein levels | Myeloid | 36 | 3 | 9 | 13 | |
| 4068 | MESD/WWP2 ratio | PRORT001519 | 8.18e-03 | Protein ratios | Hepatocyte | 0 | 4 | 13 | 18 | |
| 4069 | Deafness with mutism | AUDIO000010 | 8.13e-03 | Auditory | Hepatocyte | 0 | 1 | 9 | 18 | |
| 4070 | TNFRSF10B levels | PROLV002058 | 8.11e-03 | Protein levels | Myeloid | 21 | 0 | 3 | 2 | |
| 4071 | PTGDS levels | PROLV001664 | 8.08e-03 | Protein levels | Renal epithelium | 59 | 0 | 9 | 11 | |
| 4072 | NXF1 levels | PROLV001457 | 8.06e-03 | Protein levels | Hepatocyte | 2 | 2 | 9 | 20 | |
| 4073 | MME levels | PROLV001320 | 8.06e-03 | Protein levels | Hepatocyte | 134 | 1 | 5 | 9 | |
| 4074 | PTPN1/WWP2 ratio | PRORT001718 | 8.04e-03 | Protein ratios | Muscle / cardiac | 12 | 2 | 14 | 27 | |
| 4075 | Spondylosis | MSKEL000081 | 8.04e-03 | Musculoskeletal | Stromal / connective | 9 | 3 | 7 | 18 | |
| 4076 | COLEC12/OGN ratio | PRORT000705 | 8.04e-03 | Protein ratios | Stromal / connective | 12 | 3 | 11 | 19 | |
| 4077 | RGS18 levels | PROLV001731 | 8.02e-03 | Protein levels | Myeloid | 1 | 3 | 8 | 14 | |
| 4078 | Cancer, Melanoma | MALIG000020 | 7.99e-03 | Malignancy | Lymphocyte | 121 | 2 | 5 | 25 | |
| 4079 | SCAMP3/STX4 ratio | PRORT001756 | 7.90e-03 | Protein ratios | Vascular | 3 | 2 | 8 | 11 | |
| 4080 | Lymphocyte | HEMAT000024 | 7.88e-03 | Hematologic | Lymphocyte | 2,286 | 3 | 18 | 34 | |
| 4081 | ZBTB17 levels | PROLV002210 | 7.87e-03 | Protein levels | Muscle / cardiac | 8 | 4 | 9 | 21 | |
| 4082 | PLXNA4/SRPK2 ratio | PRORT001686 | 7.86e-03 | Protein ratios | Muscle / cardiac | 7 | 3 | 10 | 37 | |
| 4083 | FAM174A levels | PROLV000763 | 7.85e-03 | Protein levels | Adipose | 0 | 1 | 9 | 10 | |
| 4084 | XXYLT1 levels | PROLV002201 | 7.82e-03 | Protein levels | Muscle / cardiac | 1 | 2 | 3 | 8 | |
| 4085 | CEP43 levels | PROLV000402 | 7.78e-03 | Protein levels | Myeloid | 8 | 4 | 9 | 17 | |
| 4086 | CLC levels | PROLV000443 | 7.76e-03 | Protein levels | Lymphocyte | 65 | 3 | 19 | 17 | |
| 4087 | DNAJC6 levels | PROLV000635 | 7.66e-03 | Protein levels | Hematopoietic progenitor | 9 | 5 | 7 | 15 | |
| 4088 | LYN/YES1 ratio | PRORT001474 | 7.59e-03 | Protein ratios | Hepatocyte | 6 | 2 | 8 | 19 | |
| 4089 | NUDT5/RWDD1 ratio | PRORT001609 | 7.51e-03 | Protein ratios | Myeloid | 10 | 6 | 14 | 32 | |
| 4090 | Ventricular mass | CARDI000012 | 7.47e-03 | Cardiac | Muscle / cardiac | 10 | 3 | 10 | 25 | |
| 4091 | CDC26 levels | PROLV000366 | 7.45e-03 | Protein levels | Vascular | 2 | 2 | 6 | 23 | |
| 4092 | HAO1 levels | PROLV000951 | 7.43e-03 | Protein levels | Hepatocyte | 87 | 1 | 6 | 9 | |
| 4093 | Dorsopathy | MSKEL000075 | 7.41e-03 | Musculoskeletal | Stromal / connective | 14 | 2 | 7 | 22 | |
| 4094 | TFF3 levels | PROLV002014 | 7.39e-03 | Protein levels | Pancreatic epithelium | 24 | 0 | 3 | 5 | |
| 4095 | RSPO3 levels | PROLV001759 | 7.39e-03 | Protein levels | Muscle / cardiac | 0 | 4 | 9 | 25 | |
| 4096 | LRIG3 levels | PROLV001228 | 7.34e-03 | Protein levels | Lymphocyte | 0 | 0 | 9 | 20 | |
| 4097 | Transient ischaemic attack | VASCU000019 | 7.29e-03 | Vascular | Vascular | 0 | 0 | 3 | 4 | |
| 4098 | SEZ6L levels | PROLV001841 | 7.25e-03 | Protein levels | Myeloid | 76 | 2 | 8 | 7 | |
| 4099 | DAG1/PLA2G4A ratio | PRORT000852 | 7.22e-03 | Protein ratios | Myeloid | 1 | 2 | 7 | 9 | |
| 4100 | TNFRSF1B levels | PROLV002069 | 7.14e-03 | Protein levels | Lymphocyte | 74 | 1 | 7 | 21 | |
| 4101 | Intrahepatic cholestasis of pregnancy, ICP | HPBIL000001 | 7.11e-03 | Hepatopancreatobiliary | Hepatocyte | 97 | 1 | 6 | 8 | |
| 4102 | DFFA/SIRT2 ratio | PRORT000888 | 7.06e-03 | Protein ratios | Hepatocyte | 21 | 3 | 11 | 15 | |
| 4103 | Cancer, Thyroid | MALIG000032 | 7.05e-03 | Malignancy | Lymphocyte | 2 | 1 | 9 | 30 | |
| 4104 | Urbanicity | SOCIO000029 | 7.04e-03 | Socioeconomic | Melanocyte | 0 | 3 | 9 | 12 | |
| 4105 | Skin and soft tissue infection | IMMUN000073 | 6.95e-03 | Immunologic | B / plasma cell | 9 | 1 | 8 | 22 | |
| 4106 | Male-pattern baldness | DERMA000032 | 6.85e-03 | Dermatologic | Stromal / connective | 74 | 0 | 4 | 6 | |
| 4107 | FCAMR levels | PROLV000774 | 6.79e-03 | Protein levels | Hepatocyte | 81 | 2 | 8 | 20 | |
| 4108 | Prolapse, pelvic organ | REPRO000025 | 6.78e-03 | Reproductive | Stromal / connective | 35 | 3 | 6 | 13 | |
| 4109 | Iron content, Pancreas | METBL000017 | 6.72e-03 | Metabolic | Muscle / cardiac | 0 | 0 | 2 | 11 | |
| 4110 | RNASE4 levels | PROLV001739 | 6.71e-03 | Protein levels | Hepatocyte | 43 | 2 | 7 | 16 | |
| 4111 | MNDA/NCF2 ratio | PRORT001550 | 6.70e-03 | Protein ratios | Myeloid | 13 | 2 | 5 | 6 | |
| 4112 | TNFRSF13C levels | PROLV002064 | 6.69e-03 | Protein levels | B / plasma cell | 45 | 3 | 7 | 22 | |
| 4113 | TPP1 levels | PROLV002097 | 6.62e-03 | Protein levels | Myeloid | 47 | 4 | 11 | 16 | |
| 4114 | Mental distress | PSYCH000014 | 6.60e-03 | Psychiatric | Muscle / cardiac | 2 | 7 | 11 | 20 | |
| 4115 | LYN/SIRT2 ratio | PRORT001472 | 6.58e-03 | Protein ratios | Lymphocyte | 5 | 1 | 5 | 11 | |
| 4116 | CLEC1B/PLXNA4 ratio | PRORT000646 | 6.56e-03 | Protein ratios | Myeloid | 21 | 4 | 12 | 32 | |
| 4117 | CST3/TAFA5 ratio | PRORT000787 | 6.55e-03 | Protein ratios | Myeloid | 1 | 3 | 10 | 9 | |
| 4118 | CXCL9 levels | PROLV000587 | 6.51e-03 | Protein levels | Lymphocyte | 72 | 2 | 13 | 32 | |
| 4119 | KLK1 levels | PROLV001150 | 6.49e-03 | Protein levels | Muscle / cardiac | 21 | 2 | 6 | 10 | |
| 4120 | LILRB4 levels | PROLV001215 | 6.44e-03 | Protein levels | Myeloid | 162 | 2 | 8 | 19 | |
| 4121 | Amyotrophic lateral sclerosis, ALS | NEURO000017 | 6.44e-03 | Neurologic | Myeloid | 13 | 1 | 4 | 7 | |
| 4122 | TEX101 levels | PROLV002010 | 6.41e-03 | Protein levels | Pancreatic epithelium | 0 | 0 | 5 | 7 | |
| 4123 | NOTCH2 levels | PROLV001417 | 6.37e-03 | Protein levels | Myeloid | 40 | 3 | 12 | 13 | |
| 4124 | DAG1/PDGFA ratio | PRORT000850 | 6.34e-03 | Protein ratios | Myeloid | 11 | 1 | 6 | 11 | |
| 4125 | CAMK1D levels | PROLV000259 | 6.28e-03 | Protein levels | Hepatocyte | 9 | 2 | 8 | 12 | |
| 4126 | INPP5J levels | PROLV001090 | 6.27e-03 | Protein levels | B / plasma cell | 8 | 1 | 7 | 21 | |
| 4127 | CCDC80 levels | PROLV000276 | 6.20e-03 | Protein levels | Myeloid | 30 | 2 | 6 | 14 | |
| 4128 | FSHB levels | PROLV000828 | 6.17e-03 | Protein levels | Myeloid | 0 | 1 | 7 | 14 | |
| 4129 | Pregnancy complication, premature | REPRO000033 | 6.15e-03 | Reproductive | Neural / glial | 4 | 2 | 6 | 13 | |
| 4130 | MED18/TBL1X ratio | PRORT001511 | 6.13e-03 | Protein ratios | Myeloid | 35 | 3 | 11 | 22 | |
| 4131 | CASP2 levels | PROLV000267 | 6.12e-03 | Protein levels | Lymphocyte | 16 | 3 | 6 | 29 | |
| 4132 | Gallbladder polyp | HPBIL000009 | 6.09e-03 | Hepatopancreatobiliary | Salivary epithelium | 5 | 0 | 6 | 4 | |
| 4133 | Viral haemorrhagic fever | IMMUN000075 | 6.06e-03 | Immunologic | Muscle / cardiac | 13 | 2 | 10 | 31 | |
| 4134 | EGLN1/PSIP1 ratio | PRORT001005 | 6.04e-03 | Protein ratios | Myeloid | 0 | 0 | 3 | 8 | |
| 4135 | Trigger finger | MSKEL000072 | 6.02e-03 | Musculoskeletal | Stromal / connective | 7 | 2 | 4 | 8 | |
| 4136 | BSG/IL12A_IL12B ratio | PRORT000247 | 5.99e-03 | Protein ratios | B / plasma cell | 54 | 3 | 7 | 14 | |
| 4137 | IZUMO4 levels | PROLV001123 | 5.98e-03 | Protein levels | Myeloid | 2 | 3 | 10 | 21 | |
| 4138 | Dysmenorrhea | REPRO000019 | 5.97e-03 | Reproductive | Myeloid | 1 | 2 | 6 | 12 | |
| 4139 | MRPL33 levels | PROLV001339 | 5.87e-03 | Protein levels | Hepatocyte | 21 | 3 | 13 | 11 | |
| 4140 | LAT2/YES1 ratio | PRORT001432 | 5.82e-03 | Protein ratios | Hematopoietic progenitor | 10 | 2 | 6 | 7 | |
| 4141 | CLMP/TNFRSF19 ratio | PRORT000671 | 5.75e-03 | Protein ratios | Stromal / connective | 0 | 2 | 3 | 9 | |
| 4142 | PFKFB2/SRP14 ratio | PRORT001663 | 5.73e-03 | Protein ratios | Hepatocyte | 10 | 5 | 10 | 28 | |
| 4143 | IL18RAP levels | PROLV001057 | 5.72e-03 | Protein levels | B / plasma cell | 20 | 2 | 5 | 6 | |
| 4144 | IBD-Crohn disease | IMMUN000029 | 5.71e-03 | Immunologic | Myeloid | 279 | 4 | 19 | 18 | |
| 4145 | TGFBR2/TNFRSF19 ratio | PRORT001834 | 5.67e-03 | Protein ratios | Neural / glial | 12 | 3 | 7 | 13 | |
| 4146 | EDAR/TREML2 ratio | PRORT000983 | 5.63e-03 | Protein ratios | Platelet | 14 | 2 | 6 | 11 | |
| 4147 | CD244/EDAR ratio | PRORT000407 | 5.56e-03 | Protein ratios | Hematopoietic progenitor | 8 | 4 | 5 | 12 | |
| 4148 | Enthesopathy | MSKEL000061 | 5.53e-03 | Musculoskeletal | Lymphocyte | 0 | 0 | 1 | 11 | |
| 4149 | Adjustment disorder | PSYCH000051 | 5.44e-03 | Psychiatric | Neural / glial | 0 | 5 | 6 | 16 | |
| 4150 | PAG1 levels | PROLV001487 | 5.43e-03 | Protein levels | Lymphocyte | 60 | 4 | 18 | 30 | |
| 4151 | SCAMP3/VPS53 ratio | PRORT001757 | 5.41e-03 | Protein ratios | Vascular | 0 | 2 | 9 | 19 | |
| 4152 | EGLN1/PIK3AP1 ratio | PRORT001004 | 5.34e-03 | Protein ratios | Myeloid | 2 | 2 | 6 | 9 | |
| 4153 | CXCL5/PLXNA4 ratio | PRORT000829 | 5.19e-03 | Protein ratios | Myeloid | 0 | 5 | 14 | 31 | |
| 4154 | TWF2 levels | PROLV002121 | 5.18e-03 | Protein levels | Stromal / connective | 19 | 2 | 7 | 16 | |
| 4155 | FGR/LBR ratio | PRORT001143 | 5.17e-03 | Protein ratios | Myeloid | 5 | 2 | 7 | 9 | |
| 4156 | TMSB10/TREML2 ratio | PRORT001839 | 5.15e-03 | Protein ratios | Myeloid | 1 | 2 | 8 | 13 | |
| 4157 | SLC39A14 levels | PROLV001880 | 5.13e-03 | Protein levels | Hepatocyte | 97 | 1 | 6 | 9 | |
| 4158 | DCTPP1 levels | PROLV000605 | 5.13e-03 | Protein levels | Myeloid | 47 | 2 | 11 | 16 | |
| 4159 | FBLN2 levels | PROLV000772 | 5.09e-03 | Protein levels | Myeloid | 43 | 2 | 5 | 8 | |
| 4160 | CA1/CA2 ratio | PRORT000267 | 5.03e-03 | Protein ratios | Muscle / cardiac | 0 | 1 | 7 | 11 | |
| 4161 | MESD/SNX9 ratio | PRORT001517 | 5.02e-03 | Protein ratios | Stromal / connective | 1 | 5 | 10 | 28 | |
| 4162 | FABP9 levels | PROLV000757 | 4.94e-03 | Protein levels | Cutaneous epithelium | 43 | 0 | 4 | 5 | |
| 4163 | GGT1/MME ratio | PRORT001214 | 4.93e-03 | Protein ratios | Hepatocyte | 39 | 1 | 5 | 12 | |
| 4164 | CD209/CLEC14A ratio | PRORT000395 | 4.93e-03 | Protein ratios | B / plasma cell | 0 | 2 | 5 | 7 | |
| 4165 | Stomach and duodenal disorder | GASTR000053 | 4.93e-03 | Gastrointestinal | Muscle / cardiac | 6 | 4 | 7 | 18 | |
| 4166 | ANGPT1/CPXM1 ratio | PRORT000093 | 4.91e-03 | Protein ratios | Myeloid | 18 | 2 | 7 | 12 | |
| 4167 | LGMN/TIMP1 ratio | PRORT001458 | 4.90e-03 | Protein ratios | Myeloid | 8 | 2 | 7 | 17 | |
| 4168 | Vertigo | AUDIO000021 | 4.88e-03 | Auditory | Neural / glial | 0 | 2 | 3 | 15 | |
| 4169 | ITGB1BP2/WASF1 ratio | PRORT001391 | 4.84e-03 | Protein ratios | Myeloid | 0 | 3 | 9 | 24 | |
| 4170 | HSPA1A/MGLL ratio | PRORT001303 | 4.83e-03 | Protein ratios | Myeloid | 42 | 4 | 10 | 23 | |
| 4171 | NUCB2/TXNDC5 ratio | PRORT001608 | 4.80e-03 | Protein ratios | Hepatocyte | 4 | 3 | 8 | 13 | |
| 4172 | NTN4 levels | PROLV001445 | 4.79e-03 | Protein levels | Myeloid | 0 | 1 | 4 | 10 | |
| 4173 | FCRL1/TCL1A ratio | PRORT001126 | 4.76e-03 | Protein ratios | B / plasma cell | 21 | 3 | 14 | 38 | |
| 4174 | PHLDB1 levels | PROLV001550 | 4.76e-03 | Protein levels | Myeloid | 1 | 1 | 6 | 16 | |
| 4175 | CD22/TCL1A ratio | PRORT000404 | 4.75e-03 | Protein ratios | B / plasma cell | 71 | 3 | 13 | 24 | |
| 4176 | ARHGAP25 levels | PROLV000136 | 4.75e-03 | Protein levels | Hepatocyte | 6 | 0 | 2 | 7 | |
| 4177 | LYZL2 levels | PROLV001255 | 4.73e-03 | Protein levels | Hepatocyte | 5 | 3 | 10 | 21 | |
| 4178 | Mouth ulcers | DENTA000010 | 4.67e-03 | Dental | Myeloid | 194 | 4 | 15 | 36 | |
| 4179 | Sepsis | IMMUN000071 | 4.66e-03 | Immunologic | Vascular | — | 1 | 6 | 7 | |
| 4180 | Polymyalgia rheumatica | IMMUN000038 | 4.65e-03 | Immunologic | Myeloid | 34 | 3 | 11 | 14 | |
| 4181 | MANF/SNX9 ratio | PRORT001481 | 4.65e-03 | Protein ratios | Muscle / cardiac | 0 | 2 | 10 | 23 | |
| 4182 | FCRL3 levels | PROLV000785 | 4.60e-03 | Protein levels | Lymphocyte | 48 | 2 | 9 | 18 | |
| 4183 | CD55/PTGDS ratio | PRORT000471 | 4.60e-03 | Protein ratios | Vascular | 1 | 3 | 8 | 21 | |
| 4184 | CCL19 levels | PROLV000285 | 4.58e-03 | Protein levels | Lymphocyte | 61 | 1 | 10 | 16 | |
| 4185 | BTN2A1/SMOC2 ratio | PRORT000260 | 4.45e-03 | Protein ratios | Myeloid | 49 | 4 | 8 | 21 | |
| 4186 | ART3/RGMA ratio | PRORT000145 | 4.41e-03 | Protein ratios | Muscle / cardiac | 17 | 3 | 8 | 15 | |
| 4187 | Non-cancer illness history | MISCL000030 | 4.40e-03 | Miscellaneous | Lymphocyte | 34 | 2 | 11 | 17 | |
| 4188 | MSMB levels | PROLV001341 | 4.37e-03 | Protein levels | Stromal / connective | 32 | 3 | 9 | 14 | |
| 4189 | Respiratory disease | RESPI000004 | 4.34e-03 | Respiratory | Lymphocyte | 194 | 2 | 11 | 11 | |
| 4190 | CCER2 levels | PROLV000277 | 4.34e-03 | Protein levels | Muscle / cardiac | 19 | 2 | 6 | 8 | |
| 4191 | CEP43/USP8 ratio | PRORT000602 | 4.31e-03 | Protein ratios | Myeloid | 0 | 2 | 8 | 27 | |
| 4192 | AMBP levels | PROLV000085 | 4.27e-03 | Protein levels | Epithelial | 92 | 1 | 4 | 11 | |
| 4193 | Meniscus surgery | MSKEL000050 | 4.22e-03 | Musculoskeletal | Lymphocyte | 2 | 2 | 6 | 23 | |
| 4194 | ATP5IF1/LYN ratio | PRORT000159 | 4.20e-03 | Protein ratios | B / plasma cell | 1 | 3 | 18 | 33 | |
| 4195 | Wheeze | RESPI000034 | 4.16e-03 | Respiratory | Lymphocyte | 80 | 2 | 12 | 20 | |
| 4196 | Medication, cardiovascular | VASCU000036 | 4.15e-03 | Vascular | Neural / glial | 11 | 2 | 4 | 16 | |
| 4197 | Synovium, tendon and bursa disorder | MSKEL000057 | 4.15e-03 | Musculoskeletal | Stromal / connective | 1 | 2 | 4 | 7 | |
| 4198 | CA5A levels | PROLV000246 | 4.14e-03 | Protein levels | Hepatocyte | 96 | 1 | 4 | 6 | |
| 4199 | Episcleritis | OPHTH000004 | 4.14e-03 | Ophthalmic | Muscle / cardiac | 0 | 2 | 7 | 14 | |
| 4200 | OTUD7B levels | PROLV001478 | 4.13e-03 | Protein levels | Muscle / cardiac | 2 | 4 | 6 | 14 | |
| 4201 | DDHD2 levels | PROLV000609 | 4.10e-03 | Protein levels | Vascular | 9 | 4 | 10 | 15 | |
| 4202 | ENO2/RWDD1 ratio | PRORT001029 | 4.08e-03 | Protein ratios | Lymphocyte | 15 | 4 | 16 | 49 | |
| 4203 | Leukoencephalopathy | NEURO000004 | 4.06e-03 | Neurologic | Stromal / connective | 2 | 2 | 10 | 7 | |
| 4204 | CD40/IGSF8 ratio | PRORT000444 | 4.06e-03 | Protein ratios | Muscle / cardiac | 5 | 6 | 9 | 20 | |
| 4205 | CEACAM8/MMP9 ratio | PRORT000587 | 4.04e-03 | Protein ratios | Myeloid | 32 | 2 | 9 | 12 | |
| 4206 | FHIT/MAX ratio | PRORT001145 | 4.03e-03 | Protein ratios | Muscle / cardiac | 3 | 2 | 9 | 14 | |
| 4207 | KIFBP/TACC3 ratio | PRORT001404 | 4.01e-03 | Protein ratios | Hematopoietic progenitor | 3 | 1 | 4 | 6 | |
| 4208 | MMP1 levels | PROLV001321 | 4.01e-03 | Protein levels | Hematopoietic progenitor | 57 | 6 | 11 | 19 | |
| 4209 | WNT9A levels | PROLV002194 | 4.00e-03 | Protein levels | Muscle / cardiac | 20 | 2 | 6 | 20 | |
| 4210 | KLK10 levels | PROLV001151 | 3.98e-03 | Protein levels | Myeloid | 18 | 2 | 9 | 11 | |
| 4211 | ARHGEF1 levels | PROLV000139 | 3.97e-03 | Protein levels | Myeloid | 5 | 2 | 5 | 9 | |
| 4212 | Restless legs syndrome, RLS | NEURO000012 | 3.97e-03 | Neurologic | Neural / glial | 2 | 1 | 6 | 9 | |
| 4213 | CLEC4D/MANSC1 ratio | PRORT000656 | 3.93e-03 | Protein ratios | Muscle / cardiac | 16 | 3 | 9 | 15 | |
| 4214 | BAIAP2/MME ratio | PRORT000203 | 3.90e-03 | Protein ratios | Hepatocyte | 15 | 1 | 6 | 6 | |
| 4215 | S100G levels | PROLV001772 | 3.90e-03 | Protein levels | Hepatocyte | 9 | 1 | 3 | 10 | |
| 4216 | EDAR/TACC3 ratio | PRORT000980 | 3.89e-03 | Protein ratios | Myeloid | 9 | 3 | 14 | 21 | |
| 4217 | SORCS2 levels | PROLV001919 | 3.87e-03 | Protein levels | Neural / glial | 6 | 1 | 7 | 5 | |
| 4218 | Psoriasis | IMMUN000039 | 3.87e-03 | Immunologic | Lymphocyte | 213 | 2 | 14 | 19 | |
| 4219 | CALB2 levels | PROLV000254 | 3.87e-03 | Protein levels | Pancreatic epithelium | 0 | 1 | 6 | 12 | |
| 4220 | ACAA1 levels | PROLV000008 | 3.83e-03 | Protein levels | Hepatocyte | 14 | 1 | 10 | 8 | |
| 4221 | BCL2L2 levels | PROLV000189 | 3.83e-03 | Protein levels | Vascular | 0 | 2 | 5 | 9 | |
| 4222 | CD84/VASH1 ratio | PRORT000530 | 3.80e-03 | Protein ratios | Myeloid | 3 | 5 | 11 | 23 | |
| 4223 | Neurological disorder | NEURO000008 | 3.79e-03 | Neurologic | Muscle / cardiac | 0 | 1 | 7 | 7 | |
| 4224 | KLK15 levels | PROLV001155 | 3.78e-03 | Protein levels | Hepatocyte | 35 | 1 | 9 | 7 | |
| 4225 | RGMB levels | PROLV001729 | 3.77e-03 | Protein levels | Neural / glial | 21 | 1 | 6 | 7 | |
| 4226 | ERBIN/LYN ratio | PRORT001049 | 3.76e-03 | Protein ratios | Lymphocyte | 8 | 2 | 14 | 21 | |
| 4227 | MAVS/TBL1X ratio | PRORT001501 | 3.74e-03 | Protein ratios | Lymphocyte | 1 | 2 | 14 | 35 | |
| 4228 | GZMA/GZMH ratio | PRORT001258 | 3.73e-03 | Protein ratios | Lymphocyte | 23 | 2 | 12 | 23 | |
| 4229 | Digestive system symptoms | GASTR000044 | 3.73e-03 | Gastrointestinal | Neural / glial | 9 | 4 | 10 | 35 | |
| 4230 | MPI/TACC3 ratio | PRORT001556 | 3.70e-03 | Protein ratios | Hematopoietic progenitor | 0 | 2 | 6 | 5 | |
| 4231 | GDI2 levels | PROLV000871 | 3.66e-03 | Protein levels | Hepatocyte | 0 | 4 | 12 | 35 | |
| 4232 | Skin and subcutaneous tissue disorder | DERMA000004 | 3.64e-03 | Dermatologic | Muscle / cardiac | 0 | 0 | 0 | 0 | |
| 4233 | MAX/STK24 ratio | PRORT001503 | 3.54e-03 | Protein ratios | Myeloid | 0 | 4 | 7 | 11 | |
| 4234 | Glutathione metabolites | METAB000006 | 3.53e-03 | Metabolites | Neural / glial | 0 | 0 | 0 | 1 | |
| 4235 | MESD/VASH1 ratio | PRORT001518 | 3.52e-03 | Protein ratios | Adipose | 9 | 4 | 9 | 19 | |
| 4236 | Hearing loss, sensorineural | AUDIO000008 | 3.51e-03 | Auditory | Neural / glial | 38 | 2 | 9 | 8 | |
| 4237 | DXO levels | PROLV000665 | 3.47e-03 | Protein levels | Lymphocyte | 32 | 5 | 11 | 35 | |
| 4238 | ITGB1BP2/USP8 ratio | PRORT001390 | 3.47e-03 | Protein ratios | Myeloid | 26 | 3 | 10 | 16 | |
| 4239 | CX3CL1/RGMB ratio | PRORT000811 | 3.46e-03 | Protein ratios | Vascular | 14 | 1 | 7 | 18 | |
| 4240 | Frailty, multimorbidity | METBL000012 | 3.46e-03 | Metabolic | Vascular | 188 | 3 | 10 | 10 | |
| 4241 | SDHB levels | PROLV001799 | 3.42e-03 | Protein levels | Stromal / connective | 36 | 1 | 9 | 13 | |
| 4242 | OPHN1 levels | PROLV001470 | 3.42e-03 | Protein levels | Platelet | 12 | 0 | 4 | 6 | |
| 4243 | CD300E levels | PROLV000331 | 3.39e-03 | Protein levels | Myeloid | 202 | 2 | 7 | 8 | |
| 4244 | FUT8/RSPO1 ratio | PRORT001188 | 3.38e-03 | Protein ratios | Lymphocyte | 9 | 2 | 11 | 28 | |
| 4245 | SEMA4D/TREML2 ratio | PRORT001771 | 3.38e-03 | Protein ratios | Hematopoietic progenitor | 3 | 2 | 6 | 24 | |
| 4246 | GBP2 levels | PROLV000861 | 3.33e-03 | Protein levels | Myeloid | 0 | 2 | 11 | 16 | |
| 4247 | CCN2 levels | PROLV000302 | 3.32e-03 | Protein levels | Hematopoietic progenitor | 69 | 3 | 8 | 12 | |
| 4248 | CD5L levels | PROLV000348 | 3.31e-03 | Protein levels | B / plasma cell | 208 | 2 | 11 | 26 | |
| 4249 | Hyperthyroidism, autoimmune | IMMUN000014 | 3.28e-03 | Immunologic | Lymphocyte | 60 | 2 | 13 | 28 | |
| 4250 | MRC1 levels | PROLV001338 | 3.26e-03 | Protein levels | Myeloid | 102 | 3 | 9 | 13 | |
| 4251 | Social support | SOCIO000022 | 3.26e-03 | Socioeconomic | Neural / glial | 21 | 5 | 9 | 15 | |
| 4252 | GCC1 levels | PROLV000865 | 3.24e-03 | Protein levels | Myeloid | 28 | 2 | 4 | 11 | |
| 4253 | KAZN levels | PROLV001129 | 3.24e-03 | Protein levels | Stromal / connective | 3 | 2 | 6 | 26 | |
| 4254 | AMBP/HAVCR1 ratio | PRORT000086 | 3.23e-03 | Protein ratios | Hepatocyte | 10 | 1 | 8 | 9 | |
| 4255 | ART3 levels | PROLV000147 | 3.22e-03 | Protein levels | Muscle / cardiac | 82 | 2 | 6 | 7 | |
| 4256 | CCN2/DKK1 ratio | PRORT000362 | 3.21e-03 | Protein ratios | Muscle / cardiac | 7 | 4 | 13 | 29 | |
| 4257 | Brain age gap | NIMAG000004 | 3.21e-03 | Neuroimaging | Neural / glial | 1 | 4 | 15 | 36 | |
| 4258 | Organic acids | METAB000068 | 3.20e-03 | Metabolites | Neural / glial | 3 | 0 | 1 | 8 | |
| 4259 | Optic disc area | OPHTH000029 | 3.16e-03 | Ophthalmic | Vascular | 11 | 4 | 7 | 13 | |
| 4260 | Dental caries | DENTA000004 | 3.15e-03 | Dental | Stromal / connective | 2 | 1 | 4 | 7 | |
| 4261 | Myasthenia gravis | IMMUN000035 | 3.15e-03 | Immunologic | Lymphocyte | 54 | 1 | 13 | 36 | |
| 4262 | CNST/PRKAR1A ratio | PRORT000684 | 3.14e-03 | Protein ratios | Muscle / cardiac | 7 | 3 | 7 | 17 | |
| 4263 | CD22/FCRL1 ratio | PRORT000401 | 3.14e-03 | Protein ratios | B / plasma cell | 100 | 2 | 15 | 25 | |
| 4264 | SNX9/VASH1 ratio | PRORT001802 | 3.13e-03 | Protein ratios | Stromal / connective | 0 | 2 | 3 | 9 | |
| 4265 | PRTN3/RETN ratio | PRORT001711 | 3.13e-03 | Protein ratios | Myeloid | 11 | 1 | 5 | 7 | |
| 4266 | CTBS levels | PROLV000554 | 3.07e-03 | Protein levels | Stromal / connective | 57 | 3 | 10 | 20 | |
| 4267 | Atrioventricular block | CARDI000028 | 3.07e-03 | Cardiac | Muscle / cardiac | 7 | 4 | 6 | 19 | |
| 4268 | BTN2A1 levels | PROLV000219 | 3.06e-03 | Protein levels | Renal epithelium | 90 | 0 | 5 | 4 | |
| 4269 | CEP85 levels | PROLV000403 | 3.05e-03 | Protein levels | Lymphocyte | 9 | 2 | 11 | 30 | |
| 4270 | CD300C/HAVCR2 ratio | PRORT000425 | 3.04e-03 | Protein ratios | Myeloid | 48 | 3 | 11 | 16 | |
| 4271 | UBAC1 levels | PROLV002132 | 3.01e-03 | Protein levels | Muscle / cardiac | 4 | 2 | 6 | 11 | |
| 4272 | CD40/TNFRSF14 ratio | PRORT000447 | 3.00e-03 | Protein ratios | Platelet | 8 | 2 | 9 | 14 | |
| 4273 | IDUA levels | PROLV001013 | 3.00e-03 | Protein levels | Hepatocyte | 160 | 1 | 6 | 10 | |
| 4274 | ENO2/TACC3 ratio | PRORT001032 | 2.98e-03 | Protein ratios | Myeloid | 9 | 3 | 6 | 20 | |
| 4275 | CDC42BPB levels | PROLV000369 | 2.98e-03 | Protein levels | Vascular | 6 | 1 | 4 | 9 | |
| 4276 | SIGLEC6 levels | PROLV001862 | 2.98e-03 | Protein levels | Myeloid | 115 | 2 | 5 | 11 | |
| 4277 | GZMA/LTA ratio | PRORT001260 | 2.95e-03 | Protein ratios | Lymphocyte | 33 | 3 | 11 | 34 | |
| 4278 | RUNX3 levels | PROLV001763 | 2.90e-03 | Protein levels | Hepatocyte | 0 | 2 | 4 | 5 | |
| 4279 | Hypertrophic and atrophic skin condition | DERMA000040 | 2.90e-03 | Dermatologic | Melanocyte | 9 | 1 | 4 | 9 | |
| 4280 | ANP32B levels | PROLV000102 | 2.84e-03 | Protein levels | Hepatocyte | 2 | 1 | 7 | 18 | |
| 4281 | BCAN/KLK6 ratio | PRORT000216 | 2.84e-03 | Protein ratios | Myeloid | 11 | 2 | 7 | 12 | |
| 4282 | HMBS/UBAC1 ratio | PRORT001290 | 2.83e-03 | Protein ratios | Muscle / cardiac | 9 | 1 | 8 | 5 | |
| 4283 | BANK1 levels | PROLV000178 | 2.80e-03 | Protein levels | Myeloid | 33 | 2 | 5 | 13 | |
| 4284 | GRPEL1/MME ratio | PRORT001248 | 2.80e-03 | Protein ratios | Hepatocyte | 24 | 1 | 6 | 6 | |
| 4285 | CC2D1A/TMSB10 ratio | PRORT000330 | 2.80e-03 | Protein ratios | Myeloid | 4 | 3 | 11 | 27 | |
| 4286 | Corns and callosities | DERMA000023 | 2.78e-03 | Dermatologic | Cutaneous epithelium | 3 | 0 | 3 | 3 | |
| 4287 | Precerebral arterial stenosis and occlusion | VASCU000016 | 2.77e-03 | Vascular | Stromal / connective | 91 | 2 | 11 | 22 | |
| 4288 | FEV1/FVC ratio | RESPI000021 | 2.72e-03 | Respiratory | Stromal / connective | 549 | 3 | 4 | 17 | |
| 4289 | ABHD14B/SCRN1 ratio | PRORT000006 | 2.71e-03 | Protein ratios | Hematopoietic progenitor | 1 | 2 | 7 | 10 | |
| 4290 | CD70 levels | PROLV000353 | 2.70e-03 | Protein levels | Muscle / cardiac | 6 | 3 | 11 | 20 | |
| 4291 | BAIAP2 levels | PROLV000176 | 2.69e-03 | Protein levels | Myeloid | 12 | 2 | 10 | 11 | |
| 4292 | CALCOCO1/CASP8 ratio | PRORT000292 | 2.68e-03 | Protein ratios | Muscle / cardiac | 14 | 3 | 8 | 19 | |
| 4293 | EDAR/YES1 ratio | PRORT000985 | 2.68e-03 | Protein ratios | Myeloid | 30 | 5 | 12 | 27 | |
| 4294 | Vestibular disorder | AUDIO000022 | 2.64e-03 | Auditory | Neural / glial | 0 | 2 | 4 | 13 | |
| 4295 | IRAG2 levels | PROLV001096 | 2.63e-03 | Protein levels | Vascular | 1 | 1 | 4 | 7 | |
| 4296 | MPHOSPH8/USP8 ratio | PRORT001555 | 2.61e-03 | Protein ratios | Lymphocyte | 0 | 3 | 17 | 44 | |
| 4297 | ANGPT1/EGF ratio | PRORT000095 | 2.59e-03 | Protein ratios | Hepatocyte | 12 | 3 | 12 | 9 | |
| 4298 | HLA-DMA levels | PROLV000973 | 2.58e-03 | Protein levels | Vascular | 4 | 0 | 2 | 1 | |
| 4299 | LGALS4 levels | PROLV001204 | 2.57e-03 | Protein levels | B / plasma cell | 26 | 1 | 9 | 12 | |
| 4300 | Toe deformity | MSKEL000055 | 2.55e-03 | Musculoskeletal | Myeloid | 3 | 2 | 8 | 17 | |
| 4301 | Electrolyte disorder | METBL000004 | 2.51e-03 | Metabolic | Hepatocyte | 5 | 0 | 5 | 10 | |
| 4302 | LAYN/VWC2 ratio | PRORT001436 | 2.49e-03 | Protein ratios | Hepatocyte | 3 | 3 | 10 | 17 | |
| 4303 | ARNT levels | PROLV000144 | 2.48e-03 | Protein levels | Myeloid | 24 | 3 | 9 | 11 | |
| 4304 | CALCOCO1 levels | PROLV000257 | 2.47e-03 | Protein levels | Vascular | 7 | 1 | 2 | 13 | |
| 4305 | PRKAB1 levels | PROLV001630 | 2.47e-03 | Protein levels | Lymphocyte | 16 | 3 | 12 | 25 | |
| 4306 | PVALB levels | PROLV001686 | 2.44e-03 | Protein levels | Hematopoietic progenitor | 16 | 3 | 3 | 9 | |
| 4307 | PAEP/RSPO1 ratio | PRORT001619 | 2.39e-03 | Protein ratios | Stromal / connective | 1 | 0 | 7 | 9 | |
| 4308 | IL2RB levels | PROLV001070 | 2.35e-03 | Protein levels | Lymphocyte | 0 | 2 | 8 | 33 | |
| 4309 | PTH1R levels | PROLV001668 | 2.34e-03 | Protein levels | Stromal / connective | 30 | 2 | 6 | 9 | |
| 4310 | Commuting transport | SOCIO000004 | 2.32e-03 | Socioeconomic | Neural / glial | 6 | 4 | 8 | 15 | |
| 4311 | PDCD1/TNFRSF9 ratio | PRORT001631 | 2.32e-03 | Protein ratios | Epithelial | 7 | 1 | 13 | 21 | |
| 4312 | ENO2/MGLL ratio | PRORT001026 | 2.30e-03 | Protein ratios | Muscle / cardiac | 7 | 5 | 9 | 30 | |
| 4313 | PSMD9/UBAC1 ratio | PRORT001712 | 2.30e-03 | Protein ratios | Muscle / cardiac | 4 | 1 | 4 | 8 | |
| 4314 | CDKN2D/FOXO1 ratio | PRORT000577 | 2.29e-03 | Protein ratios | Lymphocyte | 0 | 2 | 9 | 25 | |
| 4315 | Urinary retention | NEPHR000015 | 2.28e-03 | Nephrourologic | Lymphocyte | 0 | 0 | 1 | 5 | |
| 4316 | Cancer, Bladder | MALIG000009 | 2.26e-03 | Malignancy | Cutaneous epithelium | 3 | 0 | 11 | 8 | |
| 4317 | FUT3 or FUT5 levels | PROLV000838 | 2.26e-03 | Protein levels | Hepatocyte | 85 | 2 | 17 | 39 | |
| 4318 | CSNK2A1 or CSNK2B levels | PROLV000545 | 2.24e-03 | Protein levels | B / plasma cell | 1 | 0 | 8 | 5 | |
| 4319 | ANXA4/CA13 ratio | PRORT000109 | 2.24e-03 | Protein ratios | Myeloid | 0 | 2 | 9 | 18 | |
| 4320 | QDPR/THOP1 ratio | PRORT001725 | 2.23e-03 | Protein ratios | Hepatocyte | 14 | 4 | 10 | 24 | |
| 4321 | CD300E/CXCL10 ratio | PRORT000430 | 2.22e-03 | Protein ratios | Myeloid | 7 | 4 | 15 | 26 | |
| 4322 | GSTA1 levels | PROLV000939 | 2.20e-03 | Protein levels | Hepatocyte | 57 | 3 | 8 | 13 | |
| 4323 | IGFBP6 levels | PROLV001032 | 2.20e-03 | Protein levels | Hepatocyte | 24 | 1 | 5 | 7 | |
| 4324 | BAG3 levels | PROLV000174 | 2.19e-03 | Protein levels | Hepatocyte | 73 | 1 | 4 | 12 | |
| 4325 | SVEP1 levels | PROLV001982 | 2.18e-03 | Protein levels | Vascular | 7 | 2 | 7 | 4 | |
| 4326 | CA3 levels | PROLV000244 | 2.17e-03 | Protein levels | Muscle / cardiac | 7 | 3 | 8 | 23 | |
| 4327 | Cervicobrachial syndrome | MSKEL000073 | 2.15e-03 | Musculoskeletal | Muscle / cardiac | 0 | 3 | 8 | 15 | |
| 4328 | CDKN2D/TACC3 ratio | PRORT000580 | 2.14e-03 | Protein ratios | Hematopoietic progenitor | 1 | 4 | 11 | 29 | |
| 4329 | ANXA10 levels | PROLV000105 | 2.14e-03 | Protein levels | Myeloid | 9 | 0 | 4 | 4 | |
| 4330 | Stroke | VASCU000017 | 2.14e-03 | Vascular | Vascular | 37 | 2 | 4 | 11 | |
| 4331 | Hypothyroidism, postinfectious | ENDOC000014 | 2.13e-03 | Endocrine | Myeloid | — | 1 | 6 | 11 | |
| 4332 | TYRP1 levels | PROLV002130 | 2.12e-03 | Protein levels | Myeloid | 94 | 5 | 11 | 17 | |
| 4333 | STX8 levels | PROLV001970 | 2.12e-03 | Protein levels | Myeloid | 0 | 3 | 5 | 14 | |
| 4334 | TACC3/TRIAP1 ratio | PRORT001825 | 2.10e-03 | Protein ratios | Myeloid | 1 | 3 | 5 | 7 | |
| 4335 | DNAJB14 levels | PROLV000631 | 2.10e-03 | Protein levels | Muscle / cardiac | 12 | 2 | 3 | 16 | |
| 4336 | CCL3 levels | PROLV000296 | 2.09e-03 | Protein levels | Myeloid | 77 | 3 | 9 | 19 | |
| 4337 | MMP9 levels | PROLV001328 | 2.07e-03 | Protein levels | Myeloid | 87 | 3 | 10 | 21 | |
| 4338 | MGLL/STK4 ratio | PRORT001531 | 2.07e-03 | Protein ratios | Hepatocyte | 36 | 1 | 7 | 15 | |
| 4339 | PPL levels | PROLV001609 | 2.06e-03 | Protein levels | Lymphocyte | 0 | 0 | 2 | 6 | |
| 4340 | TAFA5 levels | PROLV001990 | 2.05e-03 | Protein levels | Hepatocyte | 9 | 1 | 4 | 10 | |
| 4341 | EIF4G1 levels | PROLV000698 | 2.04e-03 | Protein levels | Myeloid | 7 | 4 | 7 | 17 | |
| 4342 | BTN3A2 levels | PROLV000220 | 2.03e-03 | Protein levels | Lymphocyte | 122 | 3 | 11 | 23 | |
| 4343 | HPSE levels | PROLV000986 | 2.02e-03 | Protein levels | Lymphocyte | 29 | 3 | 8 | 20 | |
| 4344 | CDH5/LGALS4 ratio | PRORT000557 | 2.01e-03 | Protein ratios | Hepatocyte | 22 | 1 | 5 | 2 | |
| 4345 | Pulmonary nodule | RESPI000018 | 2.00e-03 | Respiratory | Lymphocyte | 2 | 3 | 19 | 36 | |
| 4346 | LAIR1 levels | PROLV001176 | 2.00e-03 | Protein levels | Myeloid | 23 | 4 | 9 | 17 | |
| 4347 | PRRT3 levels | PROLV001643 | 2.00e-03 | Protein levels | Hepatocyte | 80 | 1 | 6 | 17 | |
| 4348 | VASP levels | PROLV002152 | 1.99e-03 | Protein levels | Lymphocyte | 2 | 3 | 7 | 21 | |
| 4349 | DNAJC21 levels | PROLV000634 | 1.98e-03 | Protein levels | Lymphocyte | 2 | 2 | 12 | 18 | |
| 4350 | PMVK/RHOC ratio | PRORT001694 | 1.98e-03 | Protein ratios | Vascular | 0 | 2 | 9 | 10 | |
| 4351 | Body size, childhood | BMORP000004 | 1.98e-03 | Body morphology | Neural / glial | 188 | 2 | 5 | 5 | |
| 4352 | EFHD1 levels | PROLV000680 | 1.98e-03 | Protein levels | Myeloid | 0 | 1 | 6 | 12 | |
| 4353 | Menopausal disorder | REPRO000020 | 1.95e-03 | Reproductive | Hepatocyte | 0 | 5 | 9 | 25 | |
| 4354 | EDAR/EGF ratio | PRORT000965 | 1.94e-03 | Protein ratios | Lymphocyte | 3 | 4 | 12 | 35 | |
| 4355 | AKT1S1/MAX ratio | PRORT000065 | 1.94e-03 | Protein ratios | Myeloid | 3 | 3 | 10 | 12 | |
| 4356 | Personality disorder | PSYCH000035 | 1.94e-03 | Psychiatric | Hepatocyte | 0 | 1 | 5 | 15 | |
| 4357 | IL5RA levels | PROLV001076 | 1.93e-03 | Protein levels | B / plasma cell | 181 | 3 | 12 | 28 | |
| 4358 | MAMDC4 levels | PROLV001259 | 1.92e-03 | Protein levels | Hepatocyte | 46 | 2 | 7 | 11 | |
| 4359 | ROBO2/SFTPD ratio | PRORT001746 | 1.91e-03 | Protein ratios | Neural / glial | 15 | 1 | 5 | 19 | |
| 4360 | Vaccination | IMMUN000085 | 1.89e-03 | Immunologic | Neural / glial | 10 | 5 | 10 | 12 | |
| 4361 | CSNK1G2 levels | PROLV000543 | 1.88e-03 | Protein levels | Muscle / cardiac | 0 | 2 | 4 | 9 | |
| 4362 | Cerebrovascular disease | VASCU000013 | 1.88e-03 | Vascular | Vascular | 56 | 2 | 6 | 9 | |
| 4363 | CCL13/CCL17 ratio | PRORT000337 | 1.87e-03 | Protein ratios | Myeloid | 17 | 3 | 8 | 27 | |
| 4364 | MANF/SDC4 ratio | PRORT001480 | 1.86e-03 | Protein ratios | Myeloid | 9 | 3 | 7 | 9 | |
| 4365 | Bipolar disorder | PSYCH000023 | 1.84e-03 | Psychiatric | Neural / glial | 8 | 5 | 17 | 32 | |
| 4366 | CEP170 levels | PROLV000400 | 1.83e-03 | Protein levels | Myeloid | 1 | 1 | 5 | 11 | |
| 4367 | Medication, GERD | GASTR000014 | 1.81e-03 | Gastrointestinal | Neural / glial | 1 | 2 | 7 | 12 | |
| 4368 | PDGFB/TIMP3 ratio | PRORT001648 | 1.80e-03 | Protein ratios | Hepatocyte | 15 | 1 | 8 | 25 | |
| 4369 | TNFRSF8 levels | PROLV002073 | 1.79e-03 | Protein levels | Lymphocyte | 95 | 2 | 20 | 28 | |
| 4370 | GGT1 levels | PROLV000883 | 1.79e-03 | Protein levels | Hepatocyte | 87 | 1 | 5 | 7 | |
| 4371 | CEP43/MPHOSPH8 ratio | PRORT000599 | 1.78e-03 | Protein ratios | Myeloid | 3 | 3 | 8 | 23 | |
| 4372 | RILP/RWDD1 ratio | PRORT001742 | 1.77e-03 | Protein ratios | Myeloid | 8 | 3 | 6 | 10 | |
| 4373 | Muscular dystrophy | MSKEL000028 | 1.77e-03 | Musculoskeletal | Muscle / cardiac | 4 | 4 | 17 | 33 | |
| 4374 | Lysine | METAB000026 | 1.77e-03 | Metabolites | Hepatocyte | 1 | 2 | 7 | 16 | |
| 4375 | EGF/TNFSF14 ratio | PRORT000999 | 1.76e-03 | Protein ratios | Hepatocyte | 12 | 4 | 17 | 36 | |
| 4376 | THOP1 levels | PROLV002028 | 1.73e-03 | Protein levels | Muscle / cardiac | 14 | 5 | 6 | 13 | |
| 4377 | AHSP/CA2 ratio | PRORT000057 | 1.72e-03 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 5 | 17 | |
| 4378 | ADHD | PSYCH000033 | 1.72e-03 | Psychiatric | Hematopoietic progenitor | 15 | 3 | 3 | 9 | |
| 4379 | Consultant specialty, urology | MISCL000020 | 1.72e-03 | Miscellaneous | Neural / glial | 3 | 0 | 8 | 6 | |
| 4380 | Papulosquamous disorder | DERMA000015 | 1.70e-03 | Dermatologic | Lymphocyte | 65 | 2 | 12 | 14 | |
| 4381 | Impacted cerumen | AUDIO000002 | 1.69e-03 | Auditory | Salivary epithelium | 1 | 1 | 8 | 14 | |
| 4382 | Retinal and choroidal disorder | OPHTH000038 | 1.68e-03 | Ophthalmic | Stromal / connective | 74 | 4 | 9 | 18 | |
| 4383 | PDLIM7 levels | PROLV001529 | 1.67e-03 | Protein levels | Platelet | 2 | 0 | 3 | 14 | |
| 4384 | RNASE1 levels | PROLV001737 | 1.67e-03 | Protein levels | Myeloid | 7 | 3 | 5 | 9 | |
| 4385 | ITGB1BP2/LAT2 ratio | PRORT001383 | 1.66e-03 | Protein ratios | Platelet | 15 | 1 | 6 | 15 | |
| 4386 | Chalazion | OPHTH000017 | 1.66e-03 | Ophthalmic | Lymphocyte | 12 | 2 | 19 | 45 | |
| 4387 | COL2A1 levels | PROLV000488 | 1.64e-03 | Protein levels | Myeloid | 73 | 3 | 9 | 12 | |
| 4388 | TGFBI levels | PROLV002021 | 1.62e-03 | Protein levels | Hepatocyte | 152 | 3 | 10 | 12 | |
| 4389 | LAT/SPARC ratio | PRORT001427 | 1.62e-03 | Protein ratios | Myeloid | 1 | 2 | 7 | 7 | |
| 4390 | Pre-existing hypertension, pregnancy | VASCU000044 | 1.60e-03 | Vascular | B / plasma cell | 9 | 3 | 8 | 20 | |
| 4391 | VTI1A levels | PROLV002178 | 1.59e-03 | Protein levels | Myeloid | 10 | 2 | 9 | 20 | |
| 4392 | NFE2 levels | PROLV001397 | 1.58e-03 | Protein levels | Stromal / connective | 10 | 2 | 5 | 12 | |
| 4393 | Graves disease | IMMUN000027 | 1.57e-03 | Immunologic | Lymphocyte | 94 | 1 | 11 | 18 | |
| 4394 | BACH1/NFATC1 ratio | PRORT000196 | 1.56e-03 | Protein ratios | Hepatocyte | 6 | 1 | 8 | 11 | |
| 4395 | PHYKPL levels | PROLV001552 | 1.56e-03 | Protein levels | Lymphocyte | 3 | 2 | 6 | 16 | |
| 4396 | CDHR2/MME ratio | PRORT000563 | 1.56e-03 | Protein ratios | Hepatocyte | 52 | 1 | 8 | 7 | |
| 4397 | SEPTIN8 levels | PROLV001814 | 1.56e-03 | Protein levels | B / plasma cell | 0 | 2 | 8 | 24 | |
| 4398 | LCN2/S100A12 ratio | PRORT001444 | 1.55e-03 | Protein ratios | Myeloid | 28 | 4 | 18 | 35 | |
| 4399 | B2M levels | PROLV000169 | 1.55e-03 | Protein levels | Lymphocyte | 54 | 3 | 16 | 24 | |
| 4400 | TPK1 levels | PROLV002094 | 1.53e-03 | Protein levels | Myeloid | 14 | 2 | 8 | 11 | |
| 4401 | Bone and cartilage disorder | MSKEL000006 | 1.52e-03 | Musculoskeletal | Neural / glial | 1 | 0 | 0 | 4 | |
| 4402 | CREG1/GUSB ratio | PRORT000751 | 1.51e-03 | Protein ratios | Hepatocyte | 40 | 2 | 12 | 14 | |
| 4403 | MB levels | PROLV001281 | 1.51e-03 | Protein levels | Muscle / cardiac | 26 | 3 | 4 | 11 | |
| 4404 | KLK14 levels | PROLV001154 | 1.50e-03 | Protein levels | Neural / glial | 28 | 1 | 10 | 8 | |
| 4405 | EDAR/SDC4 ratio | PRORT000976 | 1.49e-03 | Protein ratios | Hematopoietic progenitor | 25 | 4 | 8 | 17 | |
| 4406 | CD2AP/USP8 ratio | PRORT000421 | 1.49e-03 | Protein ratios | Myeloid | 0 | 4 | 8 | 23 | |
| 4407 | ATG4A levels | PROLV000159 | 1.49e-03 | Protein levels | Vascular | 0 | 3 | 11 | 31 | |
| 4408 | Immune cell marker, B cell | HEMAT000021 | 1.49e-03 | Hematologic | Myeloid | 24 | 0 | 3 | 10 | |
| 4409 | AGXT levels | PROLV000060 | 1.49e-03 | Protein levels | Hepatocyte | 122 | 1 | 6 | 9 | |
| 4410 | PCBD1 levels | PROLV001502 | 1.48e-03 | Protein levels | Hepatocyte | 64 | 4 | 17 | 39 | |
| 4411 | Oedema | MISCL000012 | 1.46e-03 | Miscellaneous | Lymphocyte | 13 | 2 | 8 | 38 | |
| 4412 | BMP6/SPINT2 ratio | PRORT000244 | 1.46e-03 | Protein ratios | Lymphocyte | 10 | 2 | 8 | 27 | |
| 4413 | ANGPT1/PDGFA ratio | PRORT000097 | 1.46e-03 | Protein ratios | Myeloid | 16 | 2 | 8 | 16 | |
| 4414 | SMOC2 levels | PROLV001900 | 1.45e-03 | Protein levels | Stromal / connective | 4 | 0 | 1 | 2 | |
| 4415 | DNMBP/WWP2 ratio | PRORT000934 | 1.45e-03 | Protein ratios | Lymphocyte | 12 | 2 | 12 | 42 | |
| 4416 | CXCL17/SFTPA2 ratio | PRORT000824 | 1.45e-03 | Protein ratios | Myeloid | 3 | 2 | 8 | 18 | |
| 4417 | TSTA3 levels | PROLV002118 | 1.43e-03 | Protein levels | Vascular | 10 | 3 | 7 | 12 | |
| 4418 | FYB1/PPP1R12A ratio | PRORT001199 | 1.43e-03 | Protein ratios | Hepatocyte | 5 | 2 | 9 | 18 | |
| 4419 | Thyrotoxicosis | ENDOC000024 | 1.43e-03 | Endocrine | Lymphocyte | 91 | 1 | 11 | 19 | |
| 4420 | DECR1/FXN ratio | PRORT000881 | 1.43e-03 | Protein ratios | Muscle / cardiac | 6 | 5 | 9 | 22 | |
| 4421 | MMP9/PLAUR ratio | PRORT001548 | 1.42e-03 | Protein ratios | Myeloid | 53 | 3 | 7 | 15 | |
| 4422 | IL15/NCR1 ratio | PRORT001344 | 1.42e-03 | Protein ratios | Lymphocyte | 32 | 2 | 9 | 31 | |
| 4423 | SLMAP levels | PROLV001891 | 1.42e-03 | Protein levels | Myeloid | 11 | 2 | 5 | 12 | |
| 4424 | AHCY levels | PROLV000061 | 1.41e-03 | Protein levels | Vascular | 11 | 5 | 10 | 25 | |
| 4425 | FABP1/SULT2A1 ratio | PRORT001097 | 1.41e-03 | Protein ratios | Hepatocyte | 10 | 4 | 8 | 18 | |
| 4426 | Latent factor, red cell and basophil | HEMAT000037 | 1.41e-03 | Hematologic | Lymphocyte | 2 | 0 | 2 | 8 | |
| 4427 | Vitamin C | METAB000077 | 1.40e-03 | Metabolites | Lymphocyte | 4 | 2 | 10 | 33 | |
| 4428 | MANF/TXNDC5 ratio | PRORT001482 | 1.40e-03 | Protein ratios | Hepatocyte | 1 | 5 | 12 | 22 | |
| 4429 | Delivery | REPRO000004 | 1.40e-03 | Reproductive | Myeloid | 0 | 2 | 5 | 10 | |
| 4430 | GOLGA3 levels | PROLV000908 | 1.39e-03 | Protein levels | Stromal / connective | 0 | 3 | 3 | 8 | |
| 4431 | Hypothyroxinemia | ENDOC000022 | 1.39e-03 | Endocrine | Neural / glial | 0 | 3 | 11 | 16 | |
| 4432 | CD84/TREML2 ratio | PRORT000529 | 1.38e-03 | Protein ratios | B / plasma cell | 3 | 2 | 4 | 10 | |
| 4433 | Body size, birth | BMORP000017 | 1.38e-03 | Body morphology | Vascular | 12 | 2 | 6 | 9 | |
| 4434 | CKMB levels | PROLV000441 | 1.37e-03 | Protein levels | Muscle / cardiac | 9 | 3 | 10 | 26 | |
| 4435 | TNFAIP2 levels | PROLV002054 | 1.36e-03 | Protein levels | Myeloid | 10 | 2 | 4 | 10 | |
| 4436 | DUSP29 levels | PROLV000662 | 1.35e-03 | Protein levels | Muscle / cardiac | 2 | 2 | 5 | 8 | |
| 4437 | KIR2DL3 levels | PROLV001142 | 1.35e-03 | Protein levels | Lymphocyte | 134 | 2 | 10 | 19 | |
| 4438 | SMTN levels | PROLV001904 | 1.35e-03 | Protein levels | Myeloid | 2 | 1 | 1 | 7 | |
| 4439 | Insulin resistance | METBL000041 | 1.34e-03 | Metabolic | Hepatocyte | 4 | 1 | 5 | 10 | |
| 4440 | SLC5A8 levels | PROLV001884 | 1.34e-03 | Protein levels | Hepatocyte | 11 | 3 | 7 | 10 | |
| 4441 | SWAP70 levels | PROLV001983 | 1.34e-03 | Protein levels | Hepatocyte | 3 | 2 | 9 | 12 | |
| 4442 | Reimbursement for rheumatic disease | IMMUN000042 | 1.34e-03 | Immunologic | Lymphocyte | 112 | 2 | 16 | 16 | |
| 4443 | UGDH levels | PROLV002138 | 1.32e-03 | Protein levels | B / plasma cell | 21 | 4 | 12 | 33 | |
| 4444 | FUT8/TNFSF14 ratio | PRORT001192 | 1.31e-03 | Protein ratios | Adipose | 13 | 4 | 22 | 56 | |
| 4445 | KRT19 levels | PROLV001166 | 1.31e-03 | Protein levels | Respiratory epithelium | 46 | 0 | 11 | 7 | |
| 4446 | TCN1 levels | PROLV002003 | 1.31e-03 | Protein levels | Myeloid | 74 | 3 | 9 | 13 | |
| 4447 | Paroxysmal neurological disorder | NEURO000035 | 1.30e-03 | Neurologic | Neural / glial | 21 | 3 | 4 | 10 | |
| 4448 | IGFBP6/SMOC2 ratio | PRORT001338 | 1.30e-03 | Protein ratios | Adipose | 2 | 3 | 8 | 13 | |
| 4449 | PYDC1 levels | PROLV001689 | 1.29e-03 | Protein levels | Cutaneous epithelium | 85 | 2 | 9 | 10 | |
| 4450 | Plant sterols | METAB000074 | 1.28e-03 | Metabolites | Hepatocyte | 6 | 2 | 4 | 14 | |
| 4451 | Catecholamine metabolites | METAB000070 | 1.27e-03 | Metabolites | Vascular | 0 | 1 | 3 | 6 | |
| 4452 | DBNL/HSPA1A ratio | PRORT000867 | 1.27e-03 | Protein ratios | Muscle / cardiac | 3 | 2 | 11 | 18 | |
| 4453 | CLEC1B/EGF ratio | PRORT000636 | 1.26e-03 | Protein ratios | Myeloid | 5 | 1 | 8 | 8 | |
| 4454 | Atrophic skin disorder | DERMA000037 | 1.26e-03 | Dermatologic | Lymphocyte | 12 | 2 | 8 | 14 | |
| 4455 | FCER2 levels | PROLV000777 | 1.26e-03 | Protein levels | B / plasma cell | 112 | 3 | 9 | 24 | |
| 4456 | DSC2/EFEMP1 ratio | PRORT000950 | 1.25e-03 | Protein ratios | Hepatocyte | 14 | 2 | 6 | 19 | |
| 4457 | Dermatitis and eczema | DERMA000008 | 1.24e-03 | Dermatologic | Lymphocyte | 129 | 1 | 12 | 18 | |
| 4458 | SYAP1 levels | PROLV001984 | 1.24e-03 | Protein levels | Platelet | 11 | 3 | 5 | 18 | |
| 4459 | HTRA2/TRIAP1 ratio | PRORT001313 | 1.23e-03 | Protein ratios | Myeloid | 0 | 1 | 6 | 10 | |
| 4460 | SERPINE1/USP8 ratio | PRORT001779 | 1.22e-03 | Protein ratios | Lymphocyte | 0 | 4 | 16 | 40 | |
| 4461 | Pain, none | MSKEL000041 | 1.21e-03 | Musculoskeletal | Neural / glial | 10 | 7 | 9 | 20 | |
| 4462 | RNASE6 levels | PROLV001740 | 1.21e-03 | Protein levels | Myeloid | 66 | 2 | 5 | 13 | |
| 4463 | Bronchitis | RESPI000001 | 1.20e-03 | Respiratory | Lymphocyte | 7 | 1 | 11 | 21 | |
| 4464 | SPINT1 levels | PROLV001932 | 1.20e-03 | Protein levels | Cutaneous epithelium | 74 | 0 | 5 | 11 | |
| 4465 | CD48/SLAMF7 ratio | PRORT000465 | 1.19e-03 | Protein ratios | Lymphocyte | 35 | 4 | 17 | 42 | |
| 4466 | CLEC1B/DKK1 ratio | PRORT000635 | 1.17e-03 | Protein ratios | Lymphocyte | 1 | 3 | 13 | 30 | |
| 4467 | Tendinitis | MSKEL000070 | 1.17e-03 | Musculoskeletal | Neural / glial | 0 | 1 | 3 | 9 | |
| 4468 | TNFRSF13C/TNFSF13B ratio | PRORT001849 | 1.15e-03 | Protein ratios | B / plasma cell | 32 | 3 | 7 | 28 | |
| 4469 | TIA1/USP8 ratio | PRORT001837 | 1.15e-03 | Protein ratios | Hepatocyte | 12 | 3 | 11 | 37 | |
| 4470 | RBPMS2 levels | PROLV001714 | 1.15e-03 | Protein levels | Vascular | 13 | 5 | 8 | 19 | |
| 4471 | Family history, hypertension | VASCU000022 | 1.14e-03 | Vascular | Hematopoietic progenitor | 2 | 0 | 1 | 5 | |
| 4472 | Juvenile arthritis | IMMUN000032 | 1.13e-03 | Immunologic | Salivary epithelium | 29 | 1 | 8 | 31 | |
| 4473 | CCL13/CCL2 ratio | PRORT000338 | 1.13e-03 | Protein ratios | Myeloid | 8 | 3 | 7 | 10 | |
| 4474 | ENO2/ITGB1BP2 ratio | PRORT001024 | 1.13e-03 | Protein ratios | Hematopoietic progenitor | 3 | 4 | 8 | 13 | |
| 4475 | HLA-A levels | PROLV000972 | 1.11e-03 | Protein levels | Myeloid | 143 | 3 | 11 | 29 | |
| 4476 | PLEKHO1 levels | PROLV001576 | 1.11e-03 | Protein levels | Myeloid | 28 | 1 | 4 | 10 | |
| 4477 | NPHS1 levels | PROLV001421 | 1.10e-03 | Protein levels | Lymphocyte | 9 | 2 | 6 | 8 | |
| 4478 | ARHGEF12 levels | PROLV000141 | 1.10e-03 | Protein levels | Hepatocyte | 17 | 1 | 6 | 14 | |
| 4479 | CCL17/GRK5 ratio | PRORT000345 | 1.09e-03 | Protein ratios | Myeloid | 18 | 4 | 8 | 21 | |
| 4480 | CST6/NECTIN4 ratio | PRORT000792 | 1.08e-03 | Protein ratios | Epithelial | 3 | 1 | 5 | 13 | |
| 4481 | Prostate-specific antigen | REPRO000041 | 1.08e-03 | Reproductive | Salivary epithelium | 56 | 1 | 7 | 8 | |
| 4482 | Breast size | BMORP000007 | 1.07e-03 | Body morphology | Hepatocyte | 0 | 1 | 4 | 14 | |
| 4483 | BIN2/FYB1 ratio | PRORT000232 | 1.07e-03 | Protein ratios | Myeloid | 1 | 3 | 9 | 21 | |
| 4484 | Panic attack | PSYCH000031 | 1.07e-03 | Psychiatric | Muscle / cardiac | 0 | 1 | 7 | 4 | |
| 4485 | TAB2 levels | PROLV001987 | 1.06e-03 | Protein levels | Myeloid | 0 | 2 | 3 | 9 | |
| 4486 | ENO2/TXNDC5 ratio | PRORT001033 | 1.05e-03 | Protein ratios | Hematopoietic progenitor | 6 | 4 | 7 | 18 | |
| 4487 | MAP2 levels | PROLV001265 | 1.05e-03 | Protein levels | Muscle / cardiac | 9 | 2 | 5 | 9 | |
| 4488 | Anterior eye disorder | OPHTH000001 | 1.05e-03 | Ophthalmic | Lymphocyte | 38 | 3 | 15 | 21 | |
| 4489 | Ocular alignment procedures | OPHTH000026 | 1.04e-03 | Ophthalmic | Neural / glial | 1 | 2 | 5 | 18 | |
| 4490 | HNRNPK/VASH1 ratio | PRORT001294 | 1.04e-03 | Protein ratios | Myeloid | 1 | 1 | 6 | 9 | |
| 4491 | ADAMTS15/SULT2A1 ratio | PRORT000025 | 1.04e-03 | Protein ratios | Hepatocyte | 59 | 1 | 6 | 9 | |
| 4492 | CLEC4D/TGFA ratio | PRORT000657 | 1.03e-03 | Protein ratios | Myeloid | 4 | 1 | 6 | 7 | |
| 4493 | LAIR2 levels | PROLV001177 | 1.03e-03 | Protein levels | Lymphocyte | 49 | 2 | 12 | 22 | |
| 4494 | Osteochondrodysplasia | MSKEL000054 | 1.03e-03 | Musculoskeletal | B / plasma cell | 0 | 2 | 8 | 18 | |
| 4495 | SELPLG levels | PROLV001806 | 1.03e-03 | Protein levels | Myeloid | 68 | 2 | 11 | 35 | |
| 4496 | Autoimmune disease | IMMUN000023 | 1.03e-03 | Immunologic | Lymphocyte | 287 | 2 | 12 | 15 | |
| 4497 | SCLY levels | PROLV001790 | 1.02e-03 | Protein levels | Hepatocyte | 62 | 2 | 8 | 16 | |
| 4498 | CD5 levels | PROLV000344 | 1.02e-03 | Protein levels | Lymphocyte | 116 | 3 | 9 | 29 | |
| 4499 | CES2 levels | PROLV000406 | 1.01e-03 | Protein levels | Myeloid | 38 | 2 | 10 | 11 | |
| 4500 | ART3/GPC1 ratio | PRORT000144 | 1.01e-03 | Protein ratios | Muscle / cardiac | 13 | 1 | 5 | 9 | |
| 4501 | FCER2/TREML2 ratio | PRORT001123 | 9.99e-04 | Protein ratios | B / plasma cell | 13 | 3 | 7 | 12 | |
| 4502 | ADAMTS15/CLMP ratio | PRORT000024 | 9.97e-04 | Protein ratios | Hepatocyte | 35 | 1 | 10 | 13 | |
| 4503 | Pregnancy complication, oedema | REPRO000032 | 9.95e-04 | Reproductive | B / plasma cell | 3 | 0 | 3 | 2 | |
| 4504 | GIPC2 levels | PROLV000888 | 9.89e-04 | Protein levels | Hepatocyte | 4 | 2 | 5 | 11 | |
| 4505 | NT5C3A/SCRN1 ratio | PRORT001603 | 9.89e-04 | Protein ratios | Neural / glial | 12 | 5 | 6 | 20 | |
| 4506 | ACY3 levels | PROLV000020 | 9.85e-04 | Protein levels | Hepatocyte | 55 | 2 | 8 | 19 | |
| 4507 | Consultant specialty, anaesthetics | MISCL000015 | 9.82e-04 | Miscellaneous | Neural / glial | 0 | 4 | 7 | 15 | |
| 4508 | Sputum production | RESPI000033 | 9.79e-04 | Respiratory | Myeloid | 0 | 4 | 9 | 14 | |
| 4509 | OSM/TGFA ratio | PRORT001617 | 9.65e-04 | Protein ratios | Myeloid | 11 | 2 | 11 | 22 | |
| 4510 | EPHB6 levels | PROLV000720 | 9.53e-04 | Protein levels | Hepatocyte | 28 | 2 | 6 | 10 | |
| 4511 | Addison disease | ENDOC000001 | 9.43e-04 | Endocrine | Lymphocyte | 56 | 0 | 4 | 15 | |
| 4512 | CCN2/EDAR ratio | PRORT000363 | 9.43e-04 | Protein ratios | Hematopoietic progenitor | 8 | 4 | 10 | 14 | |
| 4513 | Cardiac conduction disorder | CARDI000030 | 9.37e-04 | Cardiac | Muscle / cardiac | 14 | 3 | 6 | 13 | |
| 4514 | FCRL1 levels | PROLV000783 | 9.35e-04 | Protein levels | B / plasma cell | 101 | 2 | 7 | 15 | |
| 4515 | GHRL levels | PROLV000886 | 9.33e-04 | Protein levels | Hepatocyte | 39 | 2 | 6 | 15 | |
| 4516 | AHSG levels | PROLV000065 | 9.31e-04 | Protein levels | Hepatocyte | 49 | 2 | 9 | 25 | |
| 4517 | UXS1 levels | PROLV002147 | 9.30e-04 | Protein levels | Myeloid | 16 | 2 | 8 | 9 | |
| 4518 | Knee extension strength | MSKEL000031 | 9.29e-04 | Musculoskeletal | Stromal / connective | 0 | 2 | 6 | 10 | |
| 4519 | TCL1A/TNFRSF13C ratio | PRORT001829 | 9.27e-04 | Protein ratios | B / plasma cell | 23 | 2 | 14 | 31 | |
| 4520 | Medication, macular degeneration | OPHTH000015 | 9.18e-04 | Ophthalmic | Hepatocyte | 41 | 3 | 11 | 20 | |
| 4521 | CALCOCO1/TJAP1 ratio | PRORT000303 | 9.14e-04 | Protein ratios | Muscle / cardiac | 0 | 4 | 14 | 32 | |
| 4522 | SCPEP1 levels | PROLV001792 | 8.91e-04 | Protein levels | Muscle / cardiac | 13 | 2 | 6 | 16 | |
| 4523 | Pregnancy complication, abortive | REPRO000027 | 8.86e-04 | Reproductive | Neural / glial | 0 | 5 | 7 | 18 | |
| 4524 | EDAR/TXNDC5 ratio | PRORT000984 | 8.79e-04 | Protein ratios | Myeloid | 50 | 2 | 7 | 16 | |
| 4525 | HLAE/IL15 ratio | PRORT001287 | 8.68e-04 | Protein ratios | Lymphocyte | 41 | 2 | 13 | 24 | |
| 4526 | SCGB1A1 levels | PROLV001786 | 8.67e-04 | Protein levels | Respiratory epithelium | 54 | 0 | 2 | 7 | |
| 4527 | Retinal vascular disorder | OPHTH000044 | 8.67e-04 | Ophthalmic | Vascular | 0 | 1 | 6 | 13 | |
| 4528 | DSCAM levels | PROLV000654 | 8.47e-04 | Protein levels | Myeloid | 110 | 4 | 10 | 20 | |
| 4529 | NRAC levels | PROLV001431 | 8.37e-04 | Protein levels | Myeloid | 0 | 2 | 5 | 13 | |
| 4530 | Herpes zoster | IMMUN000064 | 8.24e-04 | Immunologic | Lymphocyte | 0 | 1 | 3 | 11 | |
| 4531 | GZMH levels | PROLV000949 | 8.18e-04 | Protein levels | Lymphocyte | 95 | 2 | 13 | 29 | |
| 4532 | PRR15 levels | PROLV001641 | 8.15e-04 | Protein levels | Epithelial | 0 | 2 | 6 | 9 | |
| 4533 | FCRL5/MZB1 ratio | PRORT001135 | 8.11e-04 | Protein ratios | B / plasma cell | 4 | 2 | 3 | 3 | |
| 4534 | DAB2/LYN ratio | PRORT000839 | 8.05e-04 | Protein ratios | Myeloid | 0 | 3 | 9 | 13 | |
| 4535 | DEFA1 or DEFA1B levels | PROLV000613 | 8.02e-04 | Protein levels | Myeloid | 56 | 1 | 6 | 5 | |
| 4536 | Joint injection | MSKEL000048 | 7.98e-04 | Musculoskeletal | Neural / glial | 0 | 5 | 14 | 36 | |
| 4537 | DSG3/FABP9 ratio | PRORT000953 | 7.97e-04 | Protein ratios | Cutaneous epithelium | 2 | 0 | 4 | 6 | |
| 4538 | CLMP/PIK3IP1 ratio | PRORT000669 | 7.93e-04 | Protein ratios | Adipose | 1 | 3 | 6 | 10 | |
| 4539 | CST5 levels | PROLV000550 | 7.91e-04 | Protein levels | Gastrointestinal epithelium | 57 | 1 | 4 | 8 | |
| 4540 | RETN/RNASET2 ratio | PRORT001735 | 7.90e-04 | Protein ratios | Myeloid | 43 | 2 | 10 | 10 | |
| 4541 | ABL1/CC2D1A ratio | PRORT000008 | 7.89e-04 | Protein ratios | Lymphocyte | 4 | 1 | 7 | 21 | |
| 4542 | IL12A or IL12B levels | PROLV001044 | 7.88e-04 | Protein levels | Myeloid | 210 | 4 | 10 | 21 | |
| 4543 | FCRLB levels | PROLV000788 | 7.82e-04 | Protein levels | B / plasma cell | 86 | 3 | 8 | 21 | |
| 4544 | KLK8/WFDC12 ratio | PRORT001413 | 7.69e-04 | Protein ratios | Cutaneous epithelium | 7 | 1 | 13 | 21 | |
| 4545 | CD300E/CD59 ratio | PRORT000429 | 7.65e-04 | Protein ratios | Myeloid | 79 | 2 | 6 | 7 | |
| 4546 | TCN2 levels | PROLV002004 | 7.64e-04 | Protein levels | Myeloid | 63 | 2 | 8 | 12 | |
| 4547 | CD63/EDAR ratio | PRORT000486 | 7.64e-04 | Protein ratios | Myeloid | 0 | 5 | 10 | 12 | |
| 4548 | DOK2/GRAP2 ratio | PRORT000938 | 7.61e-04 | Protein ratios | Hematopoietic progenitor | 0 | 2 | 4 | 7 | |
| 4549 | PTPN1 levels | PROLV001671 | 7.45e-04 | Protein levels | Vascular | 7 | 4 | 7 | 22 | |
| 4550 | Intestinal infection | IMMUN000066 | 7.41e-04 | Immunologic | Vascular | 5 | 3 | 7 | 15 | |
| 4551 | CCL7 levels | PROLV000299 | 7.41e-04 | Protein levels | Myeloid | 29 | 3 | 9 | 16 | |
| 4552 | EGLN1 levels | PROLV000688 | 7.39e-04 | Protein levels | Lymphocyte | 10 | 5 | 9 | 39 | |
| 4553 | CD46/TIMP1 ratio | PRORT000461 | 7.28e-04 | Protein ratios | Lymphocyte | 6 | 2 | 10 | 32 | |
| 4554 | PALM2 levels | PROLV001490 | 7.25e-04 | Protein levels | Lymphocyte | 22 | 4 | 19 | 36 | |
| 4555 | Medication, immunosuppressive | IMMUN000084 | 7.12e-04 | Immunologic | B / plasma cell | 59 | 3 | 8 | 13 | |
| 4556 | FADD/PTPN6 ratio | PRORT001110 | 7.11e-04 | Protein ratios | Hematopoietic progenitor | 0 | 0 | 1 | 3 | |
| 4557 | IL2RA/NCR1 ratio | PRORT001351 | 7.04e-04 | Protein ratios | Lymphocyte | 29 | 3 | 8 | 38 | |
| 4558 | Skin sebum | DERMA000036 | 7.02e-04 | Dermatologic | Stromal / connective | 0 | 2 | 6 | 12 | |
| 4559 | SLAMF7/TXNDC15 ratio | PRORT001789 | 6.95e-04 | Protein ratios | Hepatocyte | 28 | 3 | 11 | 24 | |
| 4560 | SNAP29/SPARC ratio | PRORT001798 | 6.91e-04 | Protein ratios | Myeloid | 5 | 2 | 8 | 13 | |
| 4561 | KLK11/KLK8 ratio | PRORT001408 | 6.89e-04 | Protein ratios | Cutaneous epithelium | 10 | 0 | 7 | 12 | |
| 4562 | PSPN levels | PROLV001661 | 6.85e-04 | Protein levels | Stromal / connective | 26 | 4 | 9 | 11 | |
| 4563 | CD69/CEP43 ratio | PRORT000488 | 6.84e-04 | Protein ratios | Myeloid | 0 | 1 | 6 | 10 | |
| 4564 | HS6ST2 levels | PROLV000991 | 6.81e-04 | Protein levels | Muscle / cardiac | 28 | 3 | 7 | 15 | |
| 4565 | EDN1 levels | PROLV000676 | 6.80e-04 | Protein levels | Hepatocyte | 33 | 4 | 11 | 22 | |
| 4566 | Operation, cardiac | CARDI000046 | 6.79e-04 | Cardiac | Muscle / cardiac | 20 | 2 | 5 | 7 | |
| 4567 | CD160 levels | PROLV000311 | 6.78e-04 | Protein levels | Lymphocyte | 78 | 2 | 11 | 17 | |
| 4568 | Supplement use, mineral or vitamin, none | DTSUP000027 | 6.73e-04 | Diet and Supplement | Neural / glial | 2 | 5 | 8 | 19 | |
| 4569 | IGLC2 levels | PROLV001035 | 6.70e-04 | Protein levels | B / plasma cell | 51 | 3 | 15 | 23 | |
| 4570 | THY1 levels | PROLV002031 | 6.68e-04 | Protein levels | B / plasma cell | 30 | 2 | 10 | 21 | |
| 4571 | LGALS1 levels | PROLV001201 | 6.67e-04 | Protein levels | Vascular | 9 | 2 | 4 | 16 | |
| 4572 | ICAM3/SLAMF7 ratio | PRORT001328 | 6.59e-04 | Protein ratios | Myeloid | 27 | 3 | 19 | 22 | |
| 4573 | ERBIN/SNAP29 ratio | PRORT001051 | 6.58e-04 | Protein ratios | Muscle / cardiac | 0 | 3 | 9 | 18 | |
| 4574 | GPKOW levels | PROLV000925 | 6.57e-04 | Protein levels | Muscle / cardiac | 5 | 4 | 5 | 17 | |
| 4575 | Cancer, Urinary tract | MALIG000033 | 6.51e-04 | Malignancy | Lymphocyte | 4 | 1 | 13 | 11 | |
| 4576 | GUCA2A/LGALS4 ratio | PRORT001254 | 6.42e-04 | Protein ratios | Epithelial | 17 | 0 | 7 | 7 | |
| 4577 | ANXA3/ANXA4 ratio | PRORT000103 | 6.42e-04 | Protein ratios | Myeloid | 0 | 3 | 10 | 14 | |
| 4578 | Bile acid levels | HPBIL000016 | 6.41e-04 | Hepatopancreatobiliary | Hepatocyte | 12 | 1 | 5 | 10 | |
| 4579 | RELT levels | PROLV001722 | 6.41e-04 | Protein levels | Vascular | 6 | 0 | 5 | 8 | |
| 4580 | GSTA1/RBP5 ratio | PRORT001251 | 6.40e-04 | Protein ratios | Myeloid | 44 | 3 | 11 | 25 | |
| 4581 | CD84/GP6 ratio | PRORT000525 | 6.33e-04 | Protein ratios | Hepatocyte | 7 | 5 | 13 | 19 | |
| 4582 | TACC3/TBC1D23 ratio | PRORT001824 | 6.31e-04 | Protein ratios | Lymphocyte | 2 | 2 | 9 | 18 | |
| 4583 | TRIM40 levels | PROLV002109 | 6.25e-04 | Protein levels | Muscle / cardiac | 52 | 4 | 10 | 9 | |
| 4584 | Dizziness and giddiness | AUDIO000020 | 6.12e-04 | Auditory | Neural / glial | 0 | 4 | 14 | 32 | |
| 4585 | Medication, diuretic | VASCU000038 | 6.11e-04 | Vascular | Vascular | 21 | 1 | 5 | 16 | |
| 4586 | SAP18 levels | PROLV001775 | 6.11e-04 | Protein levels | Hepatocyte | 3 | 3 | 7 | 13 | |
| 4587 | Erysipelas | IMMUN000062 | 6.09e-04 | Immunologic | Hepatocyte | 19 | 2 | 6 | 19 | |
| 4588 | FSTL3/SPON2 ratio | PRORT001182 | 6.08e-04 | Protein ratios | Hepatocyte | 3 | 2 | 9 | 23 | |
| 4589 | Birth complication | REPRO000036 | 6.05e-04 | Reproductive | Muscle / cardiac | 0 | 0 | 7 | 16 | |
| 4590 | ATOX1/SNAP29 ratio | PRORT000151 | 6.03e-04 | Protein ratios | Lymphocyte | 0 | 2 | 12 | 24 | |
| 4591 | AMBN levels | PROLV000084 | 6.00e-04 | Protein levels | Myeloid | 0 | 1 | 5 | 9 | |
| 4592 | Iron | METAB000046 | 6.00e-04 | Metabolites | Muscle / cardiac | 0 | 1 | 7 | 14 | |
| 4593 | CXCL5/MESD ratio | PRORT000828 | 5.99e-04 | Protein ratios | Lymphocyte | 2 | 3 | 11 | 25 | |
| 4594 | SERPINB1/TMSB10 ratio | PRORT001775 | 5.96e-04 | Protein ratios | Muscle / cardiac | 6 | 3 | 10 | 17 | |
| 4595 | FCRL2/LY9 ratio | PRORT001130 | 5.95e-04 | Protein ratios | B / plasma cell | 27 | 2 | 8 | 38 | |
| 4596 | ART3/RGMB ratio | PRORT000146 | 5.95e-04 | Protein ratios | Myeloid | 11 | 3 | 8 | 23 | |
| 4597 | VEGFD levels | PROLV002160 | 5.92e-04 | Protein levels | Hepatocyte | 25 | 2 | 9 | 23 | |
| 4598 | KLK8/LY6D ratio | PRORT001411 | 5.89e-04 | Protein ratios | Cutaneous epithelium | 4 | 0 | 6 | 2 | |
| 4599 | LMNB1 levels | PROLV001217 | 5.89e-04 | Protein levels | Myeloid | 0 | 3 | 9 | 10 | |
| 4600 | CALCOCO1/IKBKG ratio | PRORT000295 | 5.88e-04 | Protein ratios | Muscle / cardiac | 0 | 4 | 11 | 25 | |
| 4601 | CD40LG/TNFSF14 ratio | PRORT000454 | 5.86e-04 | Protein ratios | Hepatocyte | 11 | 5 | 17 | 43 | |
| 4602 | Testicular dysfunction | REPRO000016 | 5.84e-04 | Reproductive | Hepatocyte | 14 | 3 | 12 | 33 | |
| 4603 | CFHR1 levels | PROLV000414 | 5.83e-04 | Protein levels | Neural / glial | 6 | 2 | 6 | 10 | |
| 4604 | C4BPB/ENTPD5 ratio | PRORT000266 | 5.78e-04 | Protein ratios | Hepatocyte | 28 | 3 | 9 | 9 | |
| 4605 | LAT2/MANF ratio | PRORT001429 | 5.77e-04 | Protein ratios | Myeloid | 0 | 3 | 12 | 15 | |
| 4606 | Enamel hypoplasia | DENTA000002 | 5.70e-04 | Dental | Vascular | 0 | 0 | 13 | 48 | |
| 4607 | BCL2 levels | PROLV000185 | 5.60e-04 | Protein levels | Lymphocyte | 0 | 5 | 18 | 27 | |
| 4608 | Hyperthyroidism | ENDOC000020 | 5.60e-04 | Endocrine | Lymphocyte | 62 | 1 | 10 | 16 | |
| 4609 | SSC4D levels | PROLV001947 | 5.59e-04 | Protein levels | Hepatocyte | 51 | 3 | 8 | 15 | |
| 4610 | Jaw relationship anomaly | DENTA000007 | 5.58e-04 | Dental | Neural / glial | 0 | 1 | 5 | 12 | |
| 4611 | IFNLR1 levels | PROLV001022 | 5.56e-04 | Protein levels | Hepatocyte | 49 | 2 | 7 | 19 | |
| 4612 | CCL4 levels | PROLV000297 | 5.54e-04 | Protein levels | Myeloid | 72 | 2 | 5 | 8 | |
| 4613 | KRT8 levels | PROLV001168 | 5.52e-04 | Protein levels | Adipose | 0 | 0 | 3 | 3 | |
| 4614 | CCL20 levels | PROLV000287 | 5.44e-04 | Protein levels | Myeloid | 32 | 1 | 3 | 2 | |
| 4615 | DFFA/FOXO1 ratio | PRORT000887 | 5.43e-04 | Protein ratios | Muscle / cardiac | 0 | 2 | 7 | 22 | |
| 4616 | CEP85/ZBTB16 ratio | PRORT000604 | 5.43e-04 | Protein ratios | Muscle / cardiac | 20 | 3 | 12 | 18 | |
| 4617 | TNFRSF17 levels | PROLV002066 | 5.39e-04 | Protein levels | B / plasma cell | 116 | 3 | 15 | 18 | |
| 4618 | CX3CL1/EPHB6 ratio | PRORT000808 | 5.33e-04 | Protein ratios | Vascular | 22 | 3 | 6 | 15 | |
| 4619 | OMG levels | PROLV001469 | 5.32e-04 | Protein levels | Myeloid | 53 | 2 | 7 | 9 | |
| 4620 | MST1 levels | PROLV001344 | 5.30e-04 | Protein levels | Hepatocyte | 131 | 3 | 6 | 10 | |
| 4621 | CD69/CDKN2D ratio | PRORT000487 | 5.30e-04 | Protein ratios | Vascular | 6 | 3 | 8 | 16 | |
| 4622 | Hydrocephalus | NEURO000002 | 5.24e-04 | Neurologic | Stromal / connective | 10 | 2 | 4 | 16 | |
| 4623 | FOXO3 levels | PROLV000826 | 5.19e-04 | Protein levels | Lymphocyte | 3 | 2 | 14 | 20 | |
| 4624 | Falling risk | MISCL000040 | 5.16e-04 | Miscellaneous | Neural / glial | 1 | 3 | 5 | 5 | |
| 4625 | Cancer, Pancreas | MALIG000025 | 5.15e-04 | Malignancy | Myeloid | 0 | 0 | 5 | 4 | |
| 4626 | Cardiometabolic multimorbidity | METBL000013 | 5.15e-04 | Metabolic | Hepatocyte | 17 | 2 | 7 | 9 | |
| 4627 | FAM3B levels | PROLV000766 | 5.14e-04 | Protein levels | Gastrointestinal epithelium | 66 | 0 | 6 | 7 | |
| 4628 | LYN/TACC3 ratio | PRORT001473 | 5.14e-04 | Protein ratios | B / plasma cell | 0 | 6 | 9 | 16 | |
| 4629 | FCAR/LY96 ratio | PRORT001119 | 5.11e-04 | Protein ratios | Myeloid | 17 | 5 | 13 | 18 | |
| 4630 | Ventricular outflow tract obstruction | CARDI000032 | 5.09e-04 | Cardiac | Muscle / cardiac | 0 | 2 | 13 | 27 | |
| 4631 | FYN levels | PROLV000843 | 5.09e-04 | Protein levels | Muscle / cardiac | 0 | 3 | 12 | 32 | |
| 4632 | SIRPB1 levels | PROLV001868 | 5.02e-04 | Protein levels | Myeloid | 57 | 1 | 5 | 5 | |
| 4633 | CHCHD6 levels | PROLV000425 | 5.02e-04 | Protein levels | Stromal / connective | 0 | 3 | 8 | 26 | |
| 4634 | S100A11/SERPINB8 ratio | PRORT001754 | 5.00e-04 | Protein ratios | Myeloid | 17 | 3 | 8 | 13 | |
| 4635 | CA1/CA3 ratio | PRORT000268 | 4.98e-04 | Protein ratios | B / plasma cell | 1 | 5 | 16 | 23 | |
| 4636 | EBAG9/TBCB ratio | PRORT000961 | 4.94e-04 | Protein ratios | Myeloid | 0 | 2 | 7 | 16 | |
| 4637 | Dietary restriction | DTSUP000009 | 4.90e-04 | Diet and Supplement | Neural / glial | 67 | 4 | 10 | 35 | |
| 4638 | Pregnancy complication, vomiting | REPRO000035 | 4.87e-04 | Reproductive | Lymphocyte | 0 | 1 | 8 | 25 | |
| 4639 | Polyglandular dysfunction | IMMUN000037 | 4.86e-04 | Immunologic | B / plasma cell | 0 | 3 | 10 | 21 | |
| 4640 | Orofacial cleft | DENTA000001 | 4.83e-04 | Dental | Neural / glial | 0 | 1 | 10 | 17 | |
| 4641 | MANF/PTPN6 ratio | PRORT001479 | 4.79e-04 | Protein ratios | Muscle / cardiac | 9 | 1 | 5 | 13 | |
| 4642 | RCC1 levels | PROLV001715 | 4.77e-04 | Protein levels | B / plasma cell | 14 | 2 | 8 | 21 | |
| 4643 | Seborrhoeic dermatitis | DERMA000020 | 4.72e-04 | Dermatologic | Lymphocyte | 98 | 2 | 16 | 19 | |
| 4644 | PCSK7 levels | PROLV001511 | 4.63e-04 | Protein levels | B / plasma cell | 5 | 3 | 9 | 15 | |
| 4645 | Lipid unsaturation | LIPID000079 | 4.57e-04 | Lipids | Lymphocyte | 10 | 1 | 13 | 40 | |
| 4646 | Otitis externa | AUDIO000003 | 4.56e-04 | Auditory | Muscle / cardiac | 0 | 3 | 6 | 17 | |
| 4647 | ADH1B levels | PROLV000048 | 4.54e-04 | Protein levels | Hepatocyte | 54 | 2 | 9 | 11 | |
| 4648 | CCL17/PDGFB ratio | PRORT000346 | 4.54e-04 | Protein ratios | Lymphocyte | 23 | 3 | 17 | 37 | |
| 4649 | RGMB/SMOC2 ratio | PRORT001737 | 4.53e-04 | Protein ratios | Myeloid | 30 | 4 | 10 | 19 | |
| 4650 | CXCL10 levels | PROLV000576 | 4.53e-04 | Protein levels | Myeloid | 89 | 2 | 9 | 19 | |
| 4651 | Family history, asthma | IMMUN000047 | 4.47e-04 | Immunologic | Lymphocyte | 5 | 3 | 17 | 26 | |
| 4652 | ANXA3/SERPINB1 ratio | PRORT000108 | 4.41e-04 | Protein ratios | Myeloid | 19 | 3 | 9 | 9 | |
| 4653 | PLIN1 levels | PROLV001578 | 4.40e-04 | Protein levels | Neural / glial | 0 | 2 | 3 | 12 | |
| 4654 | Glucose regulation disorder | METBL000038 | 4.39e-04 | Metabolic | Lymphocyte | 36 | 2 | 5 | 17 | |
| 4655 | Hypertensive heart disease | CARDI000038 | 4.35e-04 | Cardiac | Vascular | 23 | 0 | 1 | 8 | |
| 4656 | Fracture fixation | MSKEL000047 | 4.34e-04 | Musculoskeletal | B / plasma cell | 0 | 2 | 9 | 16 | |
| 4657 | Ventricular sphericity | CARDI000014 | 4.32e-04 | Cardiac | Muscle / cardiac | 0 | 3 | 8 | 21 | |
| 4658 | EZR levels | PROLV000739 | 4.30e-04 | Protein levels | Myeloid | 46 | 3 | 15 | 27 | |
| 4659 | Smoking effects on COPD x smoking interaction | RESPI000013 | 4.27e-04 | Respiratory | Hepatocyte | 21 | 0 | 4 | 7 | |
| 4660 | EDAR/TNFSF12 ratio | PRORT000982 | 4.26e-04 | Protein ratios | Hematopoietic progenitor | 34 | 5 | 9 | 21 | |
| 4661 | CD8A levels | PROLV000361 | 4.25e-04 | Protein levels | Lymphocyte | 149 | 2 | 10 | 16 | |
| 4662 | COLEC12/NBL1 ratio | PRORT000704 | 4.25e-04 | Protein ratios | Myeloid | 12 | 1 | 5 | 4 | |
| 4663 | PPP1R12A/SPARC ratio | PRORT001702 | 4.23e-04 | Protein ratios | Myeloid | 1 | 2 | 11 | 18 | |
| 4664 | PAEP levels | PROLV001485 | 4.23e-04 | Protein levels | Myeloid | 0 | 2 | 3 | 13 | |
| 4665 | Medication, thyroid | ENDOC000002 | 4.22e-04 | Endocrine | Lymphocyte | 202 | 1 | 13 | 19 | |
| 4666 | SEPHS1 levels | PROLV001812 | 4.19e-04 | Protein levels | Neural / glial | 0 | 2 | 6 | 8 | |
| 4667 | ARHGAP25/RNF41 ratio | PRORT000139 | 4.13e-04 | Protein ratios | Lymphocyte | 0 | 4 | 13 | 28 | |
| 4668 | CLEC1B/PPP1R2 ratio | PRORT000647 | 4.11e-04 | Protein ratios | Myeloid | 7 | 3 | 7 | 18 | |
| 4669 | Hyperparathyroidism | ENDOC000004 | 4.10e-04 | Endocrine | Hepatocyte | 0 | 3 | 8 | 17 | |
| 4670 | Medication, Crohn disease | IMMUN000081 | 4.07e-04 | Immunologic | Lymphocyte | 132 | 2 | 17 | 10 | |
| 4671 | EDAR/F11R ratio | PRORT000968 | 4.07e-04 | Protein ratios | Myeloid | 23 | 3 | 7 | 20 | |
| 4672 | CASP3/SNAP23 ratio | PRORT000320 | 4.01e-04 | Protein ratios | Muscle / cardiac | 25 | 4 | 11 | 22 | |
| 4673 | PODXL2 levels | PROLV001596 | 3.97e-04 | Protein levels | Myeloid | 123 | 2 | 9 | 10 | |
| 4674 | CA13/TYMP ratio | PRORT000273 | 3.92e-04 | Protein ratios | Myeloid | 6 | 2 | 7 | 7 | |
| 4675 | PDCD1 levels | PROLV001515 | 3.91e-04 | Protein levels | Lymphocyte | 69 | 2 | 13 | 19 | |
| 4676 | CD40/GLOD4 ratio | PRORT000443 | 3.90e-04 | Protein ratios | Muscle / cardiac | 0 | 1 | 4 | 9 | |
| 4677 | ATG4A/TPMT ratio | PRORT000150 | 3.89e-04 | Protein ratios | Neural / glial | 0 | 3 | 7 | 13 | |
| 4678 | FUT8 levels | PROLV000839 | 3.88e-04 | Protein levels | Myeloid | 28 | 3 | 8 | 30 | |
| 4679 | Tubulointerstitial kidney disease | NEPHR000025 | 3.87e-04 | Nephrourologic | Lymphocyte | 2 | 0 | 8 | 17 | |
| 4680 | Influenza | IMMUN000065 | 3.83e-04 | Immunologic | B / plasma cell | 21 | 3 | 6 | 11 | |
| 4681 | Respiratory symptom | RESPI000032 | 3.82e-04 | Respiratory | Neural / glial | 10 | 4 | 12 | 19 | |
| 4682 | CXCL5/PPIB ratio | PRORT000830 | 3.80e-04 | Protein ratios | Platelet | 1 | 6 | 12 | 30 | |
| 4683 | CXCL5/EDAR ratio | PRORT000827 | 3.79e-04 | Protein ratios | Myeloid | 9 | 3 | 10 | 24 | |
| 4684 | DPP7 levels | PROLV000648 | 3.79e-04 | Protein levels | Muscle / cardiac | 129 | 4 | 14 | 27 | |
| 4685 | Atopic dermatitis | DERMA000006 | 3.78e-04 | Dermatologic | Lymphocyte | 115 | 2 | 13 | 11 | |
| 4686 | CD74/JAM2 ratio | PRORT000504 | 3.77e-04 | Protein ratios | Myeloid | 51 | 4 | 10 | 17 | |
| 4687 | Social relationships | SOCIO000021 | 3.75e-04 | Socioeconomic | Neural / glial | 17 | 5 | 9 | 17 | |
| 4688 | PPY levels | PROLV001622 | 3.74e-04 | Protein levels | Vascular | 12 | 0 | 2 | 9 | |
| 4689 | LCN2/PRTN3 ratio | PRORT001442 | 3.72e-04 | Protein ratios | Myeloid | 25 | 3 | 10 | 13 | |
| 4690 | ENO2/HCLS1 ratio | PRORT001023 | 3.72e-04 | Protein ratios | Myeloid | 13 | 2 | 11 | 16 | |
| 4691 | Demyelinating disorder | NEURO000005 | 3.72e-04 | Neurologic | Lymphocyte | — | 2 | 15 | 26 | |
| 4692 | FCER2/TNFRSF9 ratio | PRORT001122 | 3.72e-04 | Protein ratios | B / plasma cell | 32 | 2 | 11 | 39 | |
| 4693 | CYTL1 levels | PROLV000589 | 3.65e-04 | Protein levels | Stromal / connective | 2 | 2 | 4 | 6 | |
| 4694 | CCN2/TACC3 ratio | PRORT000369 | 3.64e-04 | Protein ratios | Myeloid | 3 | 3 | 14 | 28 | |
| 4695 | Abnormal lung findings | RESPI000026 | 3.64e-04 | Respiratory | Hepatocyte | 1 | 2 | 7 | 19 | |
| 4696 | LGALS4/TIE1 ratio | PRORT001451 | 3.61e-04 | Protein ratios | Hepatocyte | 12 | 0 | 5 | 10 | |
| 4697 | HDAC8 levels | PROLV000958 | 3.58e-04 | Protein levels | B / plasma cell | — | 1 | 12 | 24 | |
| 4698 | CLIC5 levels | PROLV000458 | 3.56e-04 | Protein levels | Lymphocyte | 0 | 1 | 7 | 23 | |
| 4699 | ECHDC3 levels | PROLV000670 | 3.55e-04 | Protein levels | Hepatocyte | 45 | 2 | 7 | 7 | |
| 4700 | PIKFYVE levels | PROLV001559 | 3.50e-04 | Protein levels | Lymphocyte | 3 | 2 | 11 | 31 | |
| 4701 | EBV EA-D antibody | IMMUN000060 | 3.50e-04 | Immunologic | Muscle / cardiac | 8 | 1 | 5 | 13 | |
| 4702 | Lymphangioleiomyomatosis | RESPI000014 | 3.46e-04 | Respiratory | Muscle / cardiac | 0 | 3 | 7 | 25 | |
| 4703 | JCHAIN levels | PROLV001126 | 3.46e-04 | Protein levels | B / plasma cell | 124 | 3 | 13 | 34 | |
| 4704 | ICA1/MVK ratio | PRORT001319 | 3.43e-04 | Protein ratios | Hepatocyte | 5 | 1 | 7 | 7 | |
| 4705 | IL5RA/TNFRSF13B ratio | PRORT001352 | 3.42e-04 | Protein ratios | B / plasma cell | 63 | 3 | 16 | 21 | |
| 4706 | Medication, calcium channel blocker | VASCU000035 | 3.41e-04 | Vascular | Vascular | 18 | 1 | 4 | 14 | |
| 4707 | CD27/NBL1 ratio | PRORT000415 | 3.39e-04 | Protein ratios | B / plasma cell | 23 | 3 | 12 | 25 | |
| 4708 | MZB1/TNFRSF13B ratio | PRORT001568 | 3.39e-04 | Protein ratios | B / plasma cell | 4 | 2 | 15 | 28 | |
| 4709 | CA1 levels | PROLV000239 | 3.38e-04 | Protein levels | Lymphocyte | 0 | 2 | 13 | 28 | |
| 4710 | ALCAM/SPINT1 ratio | PRORT000076 | 3.37e-04 | Protein ratios | Respiratory epithelium | 41 | 1 | 7 | 13 | |
| 4711 | GP6/TMSB10 ratio | PRORT001237 | 3.37e-04 | Protein ratios | Myeloid | 4 | 2 | 6 | 17 | |
| 4712 | EGLN1/FOXO1 ratio | PRORT001002 | 3.32e-04 | Protein ratios | Hepatocyte | 4 | 4 | 10 | 21 | |
| 4713 | GPLD1 levels | PROLV000926 | 3.32e-04 | Protein levels | Lymphocyte | 0 | 1 | 4 | 8 | |
| 4714 | CXCL5/SPARC ratio | PRORT000833 | 3.31e-04 | Protein ratios | Myeloid | 8 | 3 | 7 | 10 | |
| 4715 | Bilirubin metabolism disorder | HPBIL000003 | 3.29e-04 | Hepatopancreatobiliary | Hepatocyte | 20 | 2 | 9 | 16 | |
| 4716 | TGOLN2 levels | PROLV002024 | 3.28e-04 | Protein levels | Myeloid | 62 | 1 | 4 | 10 | |
| 4717 | SCGB3A1 levels | PROLV001787 | 3.18e-04 | Protein levels | Respiratory epithelium | 31 | 0 | 5 | 12 | |
| 4718 | CBLIF levels | PROLV000271 | 3.17e-04 | Protein levels | Vascular | 80 | 1 | 6 | 7 | |
| 4719 | NPHS2 levels | PROLV001422 | 3.15e-04 | Protein levels | B / plasma cell | 1 | 0 | 3 | 7 | |
| 4720 | TIMP4 levels | PROLV002040 | 3.15e-04 | Protein levels | Myeloid | 28 | 1 | 4 | 6 | |
| 4721 | TG levels | PROLV002018 | 3.14e-04 | Protein levels | Gastrointestinal epithelium | 11 | 0 | 9 | 10 | |
| 4722 | BCR/FOXO1 ratio | PRORT000224 | 3.13e-04 | Protein ratios | Hepatocyte | 15 | 3 | 12 | 23 | |
| 4723 | Coeliac disease | IMMUN000026 | 3.11e-04 | Immunologic | Lymphocyte | 152 | 2 | 11 | 21 | |
| 4724 | Medication, antihypertensive | VASCU000031 | 3.09e-04 | Vascular | Vascular | 332 | 2 | 4 | 9 | |
| 4725 | NUDT5/SERPINB1 ratio | PRORT001610 | 3.05e-04 | Protein ratios | Muscle / cardiac | 0 | 5 | 11 | 22 | |
| 4726 | CAPN3 levels | PROLV000263 | 3.02e-04 | Protein levels | B / plasma cell | 0 | 2 | 9 | 11 | |
| 4727 | PLXDC1 levels | PROLV001583 | 3.01e-04 | Protein levels | Adipose | 4 | 2 | 13 | 38 | |
| 4728 | TPM2 levels | PROLV002095 | 3.01e-04 | Protein levels | Hepatocyte | 9 | 3 | 10 | 17 | |
| 4729 | PER3 levels | PROLV001537 | 2.96e-04 | Protein levels | Muscle / cardiac | 5 | 3 | 10 | 17 | |
| 4730 | PPME1/PSMD9 ratio | PRORT001700 | 2.92e-04 | Protein ratios | Hepatocyte | 3 | 3 | 13 | 27 | |
| 4731 | GAST levels | PROLV000857 | 2.92e-04 | Protein levels | Salivary epithelium | 17 | 0 | 6 | 9 | |
| 4732 | TFF2 levels | PROLV002013 | 2.86e-04 | Protein levels | Pancreatic epithelium | 17 | 1 | 2 | 5 | |
| 4733 | Age at onset of walking | NEURO000023 | 2.84e-04 | Neurologic | Neural / glial | 11 | 5 | 12 | 21 | |
| 4734 | FBP1 levels | PROLV000773 | 2.82e-04 | Protein levels | Myeloid | 45 | 4 | 11 | 14 | |
| 4735 | BCAM/LGALS4 ratio | PRORT000210 | 2.81e-04 | Protein ratios | Hepatocyte | 31 | 1 | 7 | 4 | |
| 4736 | BTN2A1/CSF1 ratio | PRORT000255 | 2.81e-04 | Protein ratios | Myeloid | 12 | 3 | 6 | 13 | |
| 4737 | Cancer, Testis | MALIG000031 | 2.80e-04 | Malignancy | B / plasma cell | 0 | 0 | 1 | 7 | |
| 4738 | IBD-Inflammatory bowel disease | IMMUN000030 | 2.80e-04 | Immunologic | Lymphocyte | 230 | 4 | 19 | 29 | |
| 4739 | Immune cell marker, pDC | HEMAT000028 | 2.78e-04 | Hematologic | Myeloid | 0 | 3 | 12 | 14 | |
| 4740 | BMPER levels | PROLV000206 | 2.78e-04 | Protein levels | Myeloid | 1 | 1 | 8 | 12 | |
| 4741 | MMP7 levels | PROLV001326 | 2.76e-04 | Protein levels | Hepatocyte | 5 | 1 | 11 | 22 | |
| 4742 | KLRD1 levels | PROLV001162 | 2.75e-04 | Protein levels | Myeloid | 163 | 2 | 11 | 15 | |
| 4743 | Medication, antimigraine | NEURO000011 | 2.70e-04 | Neurologic | Neural / glial | 0 | 2 | 7 | 8 | |
| 4744 | OGFR levels | PROLV001464 | 2.70e-04 | Protein levels | Myeloid | 15 | 1 | 3 | 9 | |
| 4745 | BCR levels | PROLV000190 | 2.66e-04 | Protein levels | Vascular | 29 | 3 | 7 | 17 | |
| 4746 | DBNL/HEXIM1 ratio | PRORT000866 | 2.66e-04 | Protein ratios | Muscle / cardiac | 0 | 2 | 8 | 15 | |
| 4747 | BAX/MAX ratio | PRORT000205 | 2.65e-04 | Protein ratios | Myeloid | 0 | 2 | 7 | 12 | |
| 4748 | EDAR/F2R ratio | PRORT000969 | 2.65e-04 | Protein ratios | Platelet | 43 | 3 | 13 | 27 | |
| 4749 | Hypothyroidism, subclinical in pregnancy | ENDOC000016 | 2.63e-04 | Endocrine | Hematopoietic progenitor | 0 | 1 | 4 | 8 | |
| 4750 | CD27/DLL1 ratio | PRORT000412 | 2.62e-04 | Protein ratios | B / plasma cell | 15 | 3 | 9 | 19 | |
| 4751 | Medication, respiratory | RESPI000007 | 2.60e-04 | Respiratory | Myeloid | 1 | 2 | 6 | 7 | |
| 4752 | Non-albumin protein levels | PROLV001459 | 2.59e-04 | Protein levels | B / plasma cell | 766 | 3 | 12 | 26 | |
| 4753 | CX3CL1/DSG2 ratio | PRORT000807 | 2.58e-04 | Protein ratios | Vascular | 33 | 1 | 6 | 8 | |
| 4754 | CXCL3/CXCL5 ratio | PRORT000825 | 2.57e-04 | Protein ratios | Myeloid | 8 | 3 | 14 | 24 | |
| 4755 | CD300C/GOLM2 ratio | PRORT000424 | 2.56e-04 | Protein ratios | Myeloid | 35 | 2 | 12 | 12 | |
| 4756 | GZMA/IL12A_IL12B ratio | PRORT001259 | 2.56e-04 | Protein ratios | B / plasma cell | 51 | 3 | 7 | 8 | |
| 4757 | PRKRA levels | PROLV001634 | 2.55e-04 | Protein levels | Myeloid | 4 | 4 | 8 | 23 | |
| 4758 | Retirement wellbeing | SOCIO000027 | 2.53e-04 | Socioeconomic | Neural / glial | 1 | 5 | 6 | 12 | |
| 4759 | SPRR3 levels | PROLV001939 | 2.53e-04 | Protein levels | Gastrointestinal epithelium | 3 | 0 | 3 | 5 | |
| 4760 | DAPP1/SDC4 ratio | PRORT000857 | 2.52e-04 | Protein ratios | Myeloid | 0 | 2 | 7 | 6 | |
| 4761 | LAT2/SDC4 ratio | PRORT001430 | 2.48e-04 | Protein ratios | Myeloid | 3 | 5 | 10 | 24 | |
| 4762 | MLN levels | PROLV001319 | 2.46e-04 | Protein levels | Hepatocyte | 83 | 1 | 4 | 9 | |
| 4763 | Secondary arthropathy | MSKEL000021 | 2.45e-04 | Musculoskeletal | Hepatocyte | — | 2 | 9 | 13 | |
| 4764 | GZMA/GZMB ratio | PRORT001257 | 2.43e-04 | Protein ratios | Lymphocyte | 44 | 2 | 12 | 21 | |
| 4765 | ATOX1/SPARC ratio | PRORT000152 | 2.43e-04 | Protein ratios | Myeloid | 10 | 1 | 6 | 11 | |
| 4766 | Erectile dysfunction | VASCU000048 | 2.37e-04 | Vascular | Neural / glial | 0 | 4 | 5 | 15 | |
| 4767 | ADIPOQ levels | PROLV000050 | 2.32e-04 | Protein levels | Muscle / cardiac | 76 | 3 | 7 | 18 | |
| 4768 | CLEC4D/HGF ratio | PRORT000655 | 2.30e-04 | Protein ratios | Hepatocyte | 60 | 1 | 8 | 10 | |
| 4769 | PLA2G4A/SPINT2 ratio | PRORT001677 | 2.29e-04 | Protein ratios | Myeloid | 16 | 4 | 10 | 23 | |
| 4770 | CD40/TIMP3 ratio | PRORT000446 | 2.29e-04 | Protein ratios | Vascular | 9 | 1 | 4 | 7 | |
| 4771 | TNFRSF13B/TNFRSF13C ratio | PRORT001846 | 2.28e-04 | Protein ratios | B / plasma cell | 23 | 4 | 9 | 15 | |
| 4772 | EDAR/TMSB10 ratio | PRORT000981 | 2.27e-04 | Protein ratios | Myeloid | 30 | 2 | 4 | 7 | |
| 4773 | NAA80 levels | PROLV001368 | 2.27e-04 | Protein levels | Vascular | 9 | 3 | 6 | 11 | |
| 4774 | MME/NT5E ratio | PRORT001540 | 2.27e-04 | Protein ratios | Hepatocyte | 24 | 1 | 4 | 9 | |
| 4775 | CD38/IL12A_IL12B ratio | PRORT000439 | 2.26e-04 | Protein ratios | Myeloid | 70 | 3 | 7 | 11 | |
| 4776 | CXCL17/LAMP3 ratio | PRORT000823 | 2.25e-04 | Protein ratios | Myeloid | 6 | 3 | 15 | 38 | |
| 4777 | SPARC/TACC3 ratio | PRORT001806 | 2.25e-04 | Protein ratios | Myeloid | 1 | 2 | 5 | 5 | |
| 4778 | EIF4G1/NFATC1 ratio | PRORT001012 | 2.23e-04 | Protein ratios | Myeloid | 0 | 1 | 8 | 14 | |
| 4779 | CCN2/SPINT2 ratio | PRORT000368 | 2.18e-04 | Protein ratios | Hepatocyte | 35 | 2 | 6 | 13 | |
| 4780 | TOR1AIP1 levels | PROLV002089 | 2.18e-04 | Protein levels | Lymphocyte | 3 | 4 | 12 | 44 | |
| 4781 | PDGFB/PPP1R12A ratio | PRORT001640 | 2.18e-04 | Protein ratios | Myeloid | 12 | 2 | 11 | 17 | |
| 4782 | SPARC/TJAP1 ratio | PRORT001807 | 2.17e-04 | Protein ratios | Myeloid | 0 | 1 | 7 | 10 | |
| 4783 | ALB/Globulin ratio | PRORT000067 | 2.16e-04 | Protein ratios | B / plasma cell | 721 | 2 | 16 | 39 | |
| 4784 | C19ORF12 levels | PROLV000221 | 2.14e-04 | Protein levels | Hepatocyte | 48 | 1 | 6 | 23 | |
| 4785 | CXADR/MME ratio | PRORT000813 | 2.13e-04 | Protein ratios | Epithelial | 21 | 1 | 3 | 6 | |
| 4786 | GZMH/KLRD1 ratio | PRORT001264 | 2.08e-04 | Protein ratios | Lymphocyte | 35 | 3 | 13 | 36 | |
| 4787 | BIN2 levels | PROLV000197 | 2.07e-04 | Protein levels | Vascular | 27 | 2 | 6 | 11 | |
| 4788 | BACH1/PDLIM7 ratio | PRORT000197 | 2.06e-04 | Protein ratios | Platelet | 0 | 5 | 9 | 20 | |
| 4789 | TJAP1 levels | PROLV002043 | 2.05e-04 | Protein levels | Stromal / connective | 1 | 2 | 5 | 14 | |
| 4790 | MSTN/RGMA ratio | PRORT001564 | 2.01e-04 | Protein ratios | Muscle / cardiac | 12 | 2 | 12 | 27 | |
| 4791 | SIRT1 levels | PROLV001869 | 2.00e-04 | Protein levels | Muscle / cardiac | 6 | 2 | 11 | 20 | |
| 4792 | CCL2 levels | PROLV000286 | 1.99e-04 | Protein levels | Myeloid | 106 | 3 | 6 | 7 | |
| 4793 | CA2/PSMG3 ratio | PRORT000277 | 1.99e-04 | Protein ratios | Lymphocyte | 3 | 3 | 4 | 19 | |
| 4794 | CD69/EDAR ratio | PRORT000491 | 1.98e-04 | Protein ratios | Myeloid | 21 | 4 | 11 | 22 | |
| 4795 | Neuropathic arthropathy | MSKEL000017 | 1.97e-04 | Musculoskeletal | Myeloid | — | 1 | 7 | 11 | |
| 4796 | LAT/LYN ratio | PRORT001422 | 1.96e-04 | Protein ratios | Lymphocyte | 0 | 2 | 17 | 49 | |
| 4797 | TFF1 levels | PROLV002012 | 1.95e-04 | Protein levels | Salivary epithelium | 15 | 1 | 2 | 7 | |
| 4798 | Nephrotic syndrome | NEPHR000011 | 1.91e-04 | Nephrourologic | B / plasma cell | — | 3 | 8 | 28 | |
| 4799 | FXYD5/TMSB10 ratio | PRORT001196 | 1.90e-04 | Protein ratios | Muscle / cardiac | 6 | 3 | 6 | 18 | |
| 4800 | PPP1R14A levels | PROLV001614 | 1.87e-04 | Protein levels | Neural / glial | 11 | 2 | 7 | 11 | |
| 4801 | CD84/SDC4 ratio | PRORT000526 | 1.86e-04 | Protein ratios | Myeloid | 19 | 2 | 10 | 13 | |
| 4802 | Bleeding gums | DENTA000011 | 1.83e-04 | Dental | Lymphocyte | 0 | 0 | 12 | 15 | |
| 4803 | NQO2 levels | PROLV001430 | 1.82e-04 | Protein levels | Muscle / cardiac | 22 | 1 | 6 | 13 | |
| 4804 | PLA2G2A levels | PROLV001568 | 1.80e-04 | Protein levels | Myeloid | 20 | 3 | 9 | 17 | |
| 4805 | NFATC3 levels | PROLV001396 | 1.79e-04 | Protein levels | B / plasma cell | 57 | 3 | 10 | 17 | |
| 4806 | EIF4G1/FOXO1 ratio | PRORT001009 | 1.79e-04 | Protein ratios | Lymphocyte | 0 | 2 | 7 | 26 | |
| 4807 | JAM2/TNFRSF19 ratio | PRORT001400 | 1.78e-04 | Protein ratios | Hematopoietic progenitor | 14 | 2 | 2 | 8 | |
| 4808 | SERPINB6/TXNDC5 ratio | PRORT001776 | 1.74e-04 | Protein ratios | Myeloid | 0 | 3 | 9 | 10 | |
| 4809 | DUSP3 levels | PROLV000663 | 1.70e-04 | Protein levels | Myeloid | 6 | 1 | 7 | 11 | |
| 4810 | BOLA2 or BOLA2B levels | PROLV000208 | 1.70e-04 | Protein levels | Lymphocyte | 3 | 2 | 7 | 24 | |
| 4811 | PDGFB/SNAP29 ratio | PRORT001644 | 1.70e-04 | Protein ratios | Myeloid | 15 | 2 | 12 | 13 | |
| 4812 | PPP1R2/TACC3 ratio | PRORT001705 | 1.69e-04 | Protein ratios | Lymphocyte | 3 | 3 | 10 | 25 | |
| 4813 | Radiotherapy | MALIG000049 | 1.68e-04 | Malignancy | Muscle / cardiac | 0 | 3 | 10 | 19 | |
| 4814 | IKBKG levels | PROLV001041 | 1.67e-04 | Protein levels | Hepatocyte | 7 | 1 | 5 | 13 | |
| 4815 | CETN2 levels | PROLV000408 | 1.67e-04 | Protein levels | Platelet | 1 | 2 | 9 | 19 | |
| 4816 | Dissociative disorder | PSYCH000012 | 1.65e-04 | Psychiatric | Lymphocyte | 0 | 2 | 14 | 19 | |
| 4817 | DNAJA2/SCAMP3 ratio | PRORT000925 | 1.64e-04 | Protein ratios | Hepatocyte | 8 | 4 | 8 | 17 | |
| 4818 | Vitamin B12 deficiency anaemia | HEMAT000014 | 1.64e-04 | Hematologic | Lymphocyte | 25 | 1 | 6 | 10 | |
| 4819 | KLRB1 levels | PROLV001161 | 1.64e-04 | Protein levels | Lymphocyte | 88 | 2 | 17 | 26 | |
| 4820 | Tenosynovitis | MSKEL000071 | 1.64e-04 | Musculoskeletal | Myeloid | 0 | 2 | 8 | 10 | |
| 4821 | Lyme borreliosis induced IL6 expression | IMMUN000067 | 1.62e-04 | Immunologic | Muscle / cardiac | 0 | 2 | 6 | 12 | |
| 4822 | Medication, anti-depressant | PSYCH000019 | 1.61e-04 | Psychiatric | Neural / glial | 5 | 3 | 8 | 8 | |
| 4823 | EBAG9/EDAR ratio | PRORT000957 | 1.61e-04 | Protein ratios | Myeloid | 27 | 4 | 12 | 16 | |
| 4824 | Medication, anti-obesity | METBL000026 | 1.61e-04 | Metabolic | Neural / glial | 0 | 1 | 4 | 11 | |
| 4825 | EDAR/PSRC1 ratio | PRORT000975 | 1.60e-04 | Protein ratios | Platelet | 0 | 6 | 9 | 20 | |
| 4826 | GET3 levels | PROLV000873 | 1.60e-04 | Protein levels | B / plasma cell | 3 | 2 | 3 | 21 | |
| 4827 | Immune disorder | IMMUN000086 | 1.52e-04 | Immunologic | Myeloid | 44 | 4 | 8 | 11 | |
| 4828 | SCRG1 levels | PROLV001793 | 1.49e-04 | Protein levels | Stromal / connective | 1 | 0 | 6 | 7 | |
| 4829 | CEP43/PLXNB3 ratio | PRORT000600 | 1.49e-04 | Protein ratios | Myeloid | 0 | 3 | 9 | 30 | |
| 4830 | DARS1/EIF4B ratio | PRORT000858 | 1.48e-04 | Protein ratios | Hepatocyte | 0 | 3 | 8 | 30 | |
| 4831 | DHX58 levels | PROLV000617 | 1.48e-04 | Protein levels | Hepatocyte | 1 | 4 | 9 | 28 | |
| 4832 | NPDC1 levels | PROLV001420 | 1.47e-04 | Protein levels | Vascular | 9 | 0 | 8 | 13 | |
| 4833 | ADH4/CA5A ratio | PRORT000038 | 1.47e-04 | Protein ratios | Hepatocyte | 30 | 2 | 14 | 26 | |
| 4834 | DKK1/VEGFA ratio | PRORT000904 | 1.47e-04 | Protein ratios | Hematopoietic progenitor | 10 | 3 | 3 | 10 | |
| 4835 | COMMD1 levels | PROLV000495 | 1.46e-04 | Protein levels | Muscle / cardiac | 0 | 3 | 6 | 18 | |
| 4836 | PIBF1 levels | PROLV001555 | 1.45e-04 | Protein levels | Vascular | 7 | 1 | 5 | 11 | |
| 4837 | White blood cell disorder | HEMAT000019 | 1.44e-04 | Hematologic | Lymphocyte | 2 | 3 | 10 | 35 | |
| 4838 | CDH1/CST3 ratio | PRORT000546 | 1.43e-04 | Protein ratios | Hepatocyte | 11 | 1 | 7 | 16 | |
| 4839 | AGT levels | PROLV000059 | 1.41e-04 | Protein levels | Hepatocyte | 53 | 2 | 5 | 10 | |
| 4840 | CD5/CD6 ratio | PRORT000466 | 1.38e-04 | Protein ratios | Myeloid | 22 | 4 | 11 | 17 | |
| 4841 | GKN1 levels | PROLV000891 | 1.37e-04 | Protein levels | Vascular | 10 | 0 | 10 | 19 | |
| 4842 | ESR1 levels | PROLV000735 | 1.37e-04 | Protein levels | Adipose | 0 | 3 | 13 | 27 | |
| 4843 | External ear disorder | AUDIO000001 | 1.36e-04 | Auditory | Hepatocyte | 0 | 2 | 8 | 19 | |
| 4844 | ITGAL levels | PROLV001108 | 1.36e-04 | Protein levels | Lymphocyte | 15 | 2 | 17 | 37 | |
| 4845 | IL15 levels | PROLV001048 | 1.35e-04 | Protein levels | Lymphocyte | 114 | 2 | 12 | 20 | |
| 4846 | DBI/MESD ratio | PRORT000862 | 1.35e-04 | Protein ratios | Hepatocyte | 5 | 2 | 8 | 21 | |
| 4847 | Skin keratoses, actinic | DERMA000021 | 1.33e-04 | Dermatologic | Lymphocyte | 211 | 2 | 10 | 23 | |
| 4848 | Vitiligo | IMMUN000046 | 1.33e-04 | Immunologic | Neural / glial | — | 0 | 3 | 6 | |
| 4849 | Optic disc morphology | OPHTH000030 | 1.31e-04 | Ophthalmic | Vascular | 8 | 1 | 10 | 15 | |
| 4850 | Working hours | SOCIO000009 | 1.30e-04 | Socioeconomic | Myeloid | 0 | 2 | 7 | 7 | |
| 4851 | Degenerative skin disorder | DERMA000038 | 1.28e-04 | Dermatologic | Lymphocyte | 127 | 3 | 13 | 22 | |
| 4852 | IFNG levels | PROLV001019 | 1.27e-04 | Protein levels | Lymphocyte | 30 | 3 | 11 | 38 | |
| 4853 | GZMA levels | PROLV000947 | 1.26e-04 | Protein levels | Myeloid | 161 | 3 | 5 | 15 | |
| 4854 | CA6/DNER ratio | PRORT000289 | 1.26e-04 | Protein ratios | Myeloid | 17 | 2 | 13 | 14 | |
| 4855 | LIPF levels | PROLV001216 | 1.25e-04 | Protein levels | Epithelial | 5 | 0 | 1 | 2 | |
| 4856 | ARHGAP30 levels | PROLV000137 | 1.23e-04 | Protein levels | Lymphocyte | 10 | 3 | 12 | 40 | |
| 4857 | CDC27 levels | PROLV000367 | 1.23e-04 | Protein levels | Lymphocyte | 4 | 3 | 9 | 24 | |
| 4858 | Heart rate, exercise | CARDI000017 | 1.23e-04 | Cardiac | Muscle / cardiac | 19 | 6 | 12 | 25 | |
| 4859 | VSTM2L levels | PROLV002176 | 1.21e-04 | Protein levels | Myeloid | 1 | 2 | 7 | 11 | |
| 4860 | ACE2/MME ratio | PRORT000012 | 1.20e-04 | Protein ratios | Hepatocyte | 40 | 1 | 5 | 9 | |
| 4861 | SERPINB1/SERPINB6 ratio | PRORT001773 | 1.19e-04 | Protein ratios | Myeloid | 2 | 3 | 7 | 15 | |
| 4862 | Upper gastrointestinal disorder | GASTR000054 | 1.18e-04 | Gastrointestinal | Myeloid | 0 | 1 | 7 | 13 | |
| 4863 | Medication, bone metabolism | MSKEL000025 | 1.18e-04 | Musculoskeletal | Lymphocyte | — | 2 | 10 | 27 | |
| 4864 | ELOA/POLR2F ratio | PRORT001016 | 1.18e-04 | Protein ratios | Muscle / cardiac | 0 | 3 | 16 | 28 | |
| 4865 | CD1C levels | PROLV000315 | 1.17e-04 | Protein levels | Myeloid | 118 | 2 | 7 | 9 | |
| 4866 | GFRA1 levels | PROLV000876 | 1.16e-04 | Protein levels | Myeloid | 22 | 2 | 8 | 15 | |
| 4867 | Drug hypersensitivity | IMMUN000006 | 1.15e-04 | Immunologic | Lymphocyte | 23 | 4 | 14 | 32 | |
| 4868 | CD27 levels | PROLV000324 | 1.15e-04 | Protein levels | B / plasma cell | 60 | 3 | 16 | 24 | |
| 4869 | CD2AP levels | PROLV000328 | 1.15e-04 | Protein levels | Vascular | 8 | 3 | 8 | 33 | |
| 4870 | Knee morphology | MSKEL000024 | 1.14e-04 | Musculoskeletal | Stromal / connective | 0 | 4 | 7 | 17 | |
| 4871 | CDSN/WFDC12 ratio | PRORT000585 | 1.13e-04 | Protein ratios | Lymphocyte | 41 | 3 | 12 | 32 | |
| 4872 | ProBNP | CARDI000002 | 1.13e-04 | Cardiac | B / plasma cell | 0 | 3 | 5 | 16 | |
| 4873 | SULT2A1 levels | PROLV001974 | 1.13e-04 | Protein levels | Hepatocyte | 51 | 1 | 4 | 21 | |
| 4874 | Mosaic chromosomal alteration | MISCL000014 | 1.12e-04 | Miscellaneous | Hematopoietic progenitor | 143 | 3 | 12 | 18 | |
| 4875 | BCR/ITGB1BP2 ratio | PRORT000227 | 1.12e-04 | Protein ratios | Muscle / cardiac | 20 | 3 | 9 | 24 | |
| 4876 | FUT8/SPARC ratio | PRORT001190 | 1.12e-04 | Protein ratios | Lymphocyte | 1 | 1 | 10 | 24 | |
| 4877 | MAVS/ZBTB16 ratio | PRORT001502 | 1.11e-04 | Protein ratios | Muscle / cardiac | 10 | 4 | 5 | 11 | |
| 4878 | GCHFR levels | PROLV000867 | 1.10e-04 | Protein levels | Hepatocyte | 2 | 2 | 13 | 40 | |
| 4879 | METAP1D/VASH1 ratio | PRORT001522 | 1.09e-04 | Protein ratios | Hematopoietic progenitor | 4 | 2 | 5 | 11 | |
| 4880 | TNFRSF13B/TNFRSF9 ratio | PRORT001847 | 1.09e-04 | Protein ratios | B / plasma cell | 19 | 2 | 14 | 28 | |
| 4881 | Eye disorder, none | OPHTH000007 | 1.08e-04 | Ophthalmic | Neural / glial | — | 4 | 14 | 11 | |
| 4882 | APP/TMSB10 ratio | PRORT000131 | 1.07e-04 | Protein ratios | Myeloid | 9 | 2 | 7 | 10 | |
| 4883 | IFI30 levels | PROLV001014 | 1.07e-04 | Protein levels | Myeloid | 93 | 4 | 19 | 45 | |
| 4884 | SERPINA6 levels | PROLV001820 | 1.06e-04 | Protein levels | Hepatocyte | 34 | 2 | 10 | 13 | |
| 4885 | CDSN/LY6D ratio | PRORT000583 | 1.06e-04 | Protein ratios | Cutaneous epithelium | 33 | 2 | 18 | 32 | |
| 4886 | CCN2/VEGFC ratio | PRORT000371 | 1.02e-04 | Protein ratios | Hematopoietic progenitor | 24 | 4 | 9 | 19 | |
| 4887 | DNMBP levels | PROLV000640 | 1.02e-04 | Protein levels | Vascular | 2 | 1 | 3 | 9 | |
| 4888 | MGLL/MITD1 ratio | PRORT001527 | 1.02e-04 | Protein ratios | Hepatocyte | 42 | 3 | 11 | 16 | |
| 4889 | CXCL12/TIMP3 ratio | PRORT000821 | 1.01e-04 | Protein ratios | Vascular | 21 | 2 | 6 | 10 | |
| 4890 | HSPB6 levels | PROLV000998 | 9.95e-05 | Protein levels | Muscle / cardiac | 7 | 4 | 10 | 26 | |
| 4891 | EIF4G1/FKBP5 ratio | PRORT001008 | 9.94e-05 | Protein ratios | Hepatocyte | 20 | 1 | 6 | 10 | |
| 4892 | MAVS levels | PROLV001279 | 9.92e-05 | Protein levels | Myeloid | 7 | 3 | 3 | 11 | |
| 4893 | Oral health conditions, none | DENTA000009 | 9.83e-05 | Dental | Lymphocyte | 19 | 2 | 15 | 31 | |
| 4894 | Infective dermatitis | DERMA000012 | 9.82e-05 | Dermatologic | Lymphocyte | 8 | 3 | 14 | 18 | |
| 4895 | RAP1A levels | PROLV001704 | 9.76e-05 | Protein levels | Lymphocyte | 15 | 2 | 12 | 20 | |
| 4896 | Cough | RESPI000027 | 9.68e-05 | Respiratory | Myeloid | 0 | 4 | 7 | 11 | |
| 4897 | SERPINA7 levels | PROLV001821 | 9.55e-05 | Protein levels | Hepatocyte | 6 | 3 | 13 | 17 | |
| 4898 | CD55/CHI3L1 ratio | PRORT000469 | 9.44e-05 | Protein ratios | Hepatocyte | 11 | 2 | 9 | 24 | |
| 4899 | PPP1R12A/SKAP2 ratio | PRORT001701 | 9.38e-05 | Protein ratios | Hepatocyte | 9 | 2 | 7 | 13 | |
| 4900 | HYAL1 levels | PROLV001001 | 9.38e-05 | Protein levels | Vascular | 33 | 3 | 10 | 14 | |
| 4901 | NBN levels | PROLV001376 | 9.34e-05 | Protein levels | Lymphocyte | 10 | 2 | 14 | 38 | |
| 4902 | PLXNB2/SEMA7A ratio | PRORT001690 | 9.30e-05 | Protein ratios | B / plasma cell | 8 | 2 | 8 | 21 | |
| 4903 | Amino sugar metabolites | METAB000034 | 9.24e-05 | Metabolites | Lymphocyte | 0 | 1 | 5 | 20 | |
| 4904 | TNFRSF9 levels | PROLV002074 | 9.21e-05 | Protein levels | B / plasma cell | 81 | 1 | 15 | 24 | |
| 4905 | Bacterial infections | IMMUN000051 | 9.12e-05 | Immunologic | Myeloid | 17 | 5 | 13 | 30 | |
| 4906 | TBC1D23 levels | PROLV001996 | 9.08e-05 | Protein levels | Muscle / cardiac | 15 | 2 | 8 | 18 | |
| 4907 | ATXN2L levels | PROLV000165 | 9.04e-05 | Protein levels | Stromal / connective | 0 | 1 | 6 | 16 | |
| 4908 | ADAMTS16 levels | PROLV000033 | 8.99e-05 | Protein levels | Myeloid | 3 | 1 | 2 | 10 | |
| 4909 | Medication, dermatologic | DERMA000024 | 8.97e-05 | Dermatologic | Lymphocyte | 18 | 2 | 18 | 21 | |
| 4910 | ANXA3/EDAR ratio | PRORT000105 | 8.97e-05 | Protein ratios | Myeloid | 22 | 1 | 3 | 6 | |
| 4911 | INSL5 levels | PROLV001093 | 8.91e-05 | Protein levels | Hematopoietic progenitor | 10 | 1 | 5 | 7 | |
| 4912 | EXTL1 levels | PROLV000738 | 8.86e-05 | Protein levels | Myeloid | 13 | 4 | 13 | 17 | |
| 4913 | LAYN/PTPRN2 ratio | PRORT001433 | 8.84e-05 | Protein ratios | Neural / glial | 5 | 2 | 13 | 28 | |
| 4914 | DRAXIN levels | PROLV000651 | 8.72e-05 | Protein levels | B / plasma cell | 29 | 2 | 7 | 16 | |
| 4915 | CPXM2 levels | PROLV000512 | 8.64e-05 | Protein levels | Muscle / cardiac | 0 | 2 | 4 | 14 | |
| 4916 | Cancer, Lip | MALIG000017 | 8.63e-05 | Malignancy | Lymphocyte | 0 | 3 | 11 | 39 | |
| 4917 | IL1R2/MEGF9 ratio | PRORT001349 | 8.61e-05 | Protein ratios | Hepatocyte | 31 | 2 | 9 | 13 | |
| 4918 | Infant mortality rate | MISCL000003 | 8.56e-05 | Miscellaneous | Myeloid | 1 | 3 | 10 | 20 | |
| 4919 | Medication, antipyretic | MISCL000035 | 8.56e-05 | Miscellaneous | Lymphocyte | 0 | 3 | 10 | 20 | |
| 4920 | DDR1/SFTPD ratio | PRORT000880 | 8.51e-05 | Protein ratios | Epithelial | 18 | 1 | 5 | 6 | |
| 4921 | SERPINI1 levels | PROLV001836 | 8.43e-05 | Protein levels | Myeloid | 23 | 1 | 6 | 9 | |
| 4922 | CDSN/KLK8 ratio | PRORT000582 | 8.40e-05 | Protein ratios | Gastrointestinal epithelium | 22 | 1 | 12 | 19 | |
| 4923 | MAVS/SCAMP3 ratio | PRORT001500 | 8.36e-05 | Protein ratios | Neural / glial | 0 | 1 | 6 | 22 | |
| 4924 | DAB2/FKBP1B ratio | PRORT000836 | 8.16e-05 | Protein ratios | Muscle / cardiac | 0 | 4 | 12 | 37 | |
| 4925 | Healthcare cost | SOCIO000025 | 8.13e-05 | Socioeconomic | Neural / glial | 27 | 3 | 8 | 12 | |
| 4926 | Healthspan | AGING000004 | 7.88e-05 | Aging | Hepatocyte | 12 | 1 | 12 | 12 | |
| 4927 | Medication, analgesic or antidepressant | MISCL000033 | 7.82e-05 | Miscellaneous | Lymphocyte | 0 | 3 | 16 | 43 | |
| 4928 | STX6 levels | PROLV001969 | 7.80e-05 | Protein levels | Lymphocyte | 0 | 3 | 10 | 16 | |
| 4929 | IRAK1/SPRY2 ratio | PRORT001369 | 7.75e-05 | Protein ratios | Hepatocyte | 2 | 2 | 7 | 21 | |
| 4930 | SPOCK1 levels | PROLV001934 | 7.69e-05 | Protein levels | Neural / glial | 61 | 4 | 9 | 10 | |
| 4931 | CCL11/CCL2 ratio | PRORT000335 | 7.68e-05 | Protein ratios | Muscle / cardiac | 13 | 2 | 5 | 11 | |
| 4932 | MED18/ZBTB16 ratio | PRORT001512 | 7.63e-05 | Protein ratios | Muscle / cardiac | 10 | 1 | 3 | 13 | |
| 4933 | AAMDC levels | PROLV000004 | 7.59e-05 | Protein levels | Myeloid | 19 | 1 | 5 | 7 | |
| 4934 | FOXO1/NUB1 ratio | PRORT001175 | 7.57e-05 | Protein ratios | Myeloid | 0 | 2 | 13 | 20 | |
| 4935 | CCDC50 levels | PROLV000275 | 7.55e-05 | Protein levels | B / plasma cell | 0 | 4 | 7 | 12 | |
| 4936 | BTN2A1/SPINT2 ratio | PRORT000261 | 7.46e-05 | Protein ratios | Hepatocyte | 30 | 2 | 9 | 16 | |
| 4937 | CD83/IL12A_IL12B ratio | PRORT000516 | 7.45e-05 | Protein ratios | B / plasma cell | 66 | 3 | 11 | 16 | |
| 4938 | AGRN levels | PROLV000057 | 7.33e-05 | Protein levels | Stromal / connective | 53 | 0 | 2 | 8 | |
| 4939 | UPB1 levels | PROLV002142 | 7.20e-05 | Protein levels | Hepatocyte | 31 | 1 | 5 | 11 | |
| 4940 | SRPK2/VASH1 ratio | PRORT001815 | 7.12e-05 | Protein ratios | Muscle / cardiac | 0 | 4 | 12 | 25 | |
| 4941 | POMC levels | PROLV001599 | 6.98e-05 | Protein levels | B / plasma cell | 28 | 1 | 3 | 12 | |
| 4942 | Glomerular disease | NEPHR000006 | 6.97e-05 | Nephrourologic | Adipose | 5 | 2 | 3 | 9 | |
| 4943 | MZB1 levels | PROLV001366 | 6.96e-05 | Protein levels | Lymphocyte | 62 | 2 | 12 | 17 | |
| 4944 | SPINK1 levels | PROLV001927 | 6.96e-05 | Protein levels | Pancreatic epithelium | 75 | 0 | 6 | 9 | |
| 4945 | Gut microbial abundance, Rubneribacter | GASTR000035 | 6.96e-05 | Gastrointestinal | Neural / glial | 0 | 2 | 10 | 19 | |
| 4946 | MPIG6B/PDGFB ratio | PRORT001557 | 6.94e-05 | Protein ratios | Myeloid | 3 | 4 | 11 | 21 | |
| 4947 | TNFSF13B levels | PROLV002079 | 6.93e-05 | Protein levels | B / plasma cell | 111 | 3 | 10 | 29 | |
| 4948 | GNLY/GZMA ratio | PRORT001221 | 6.93e-05 | Protein ratios | Lymphocyte | 41 | 3 | 18 | 47 | |
| 4949 | DBNL/EDAR ratio | PRORT000865 | 6.82e-05 | Protein ratios | Myeloid | 31 | 4 | 14 | 22 | |
| 4950 | SNAP23/SNAP29 ratio | PRORT001793 | 6.76e-05 | Protein ratios | Lymphocyte | 0 | 3 | 7 | 15 | |
| 4951 | MEPE/SOST ratio | PRORT001515 | 6.72e-05 | Protein ratios | Myeloid | 4 | 3 | 6 | 12 | |
| 4952 | CLEC4C levels | PROLV000451 | 6.68e-05 | Protein levels | Myeloid | 124 | 4 | 9 | 15 | |
| 4953 | CA9/CBLIF ratio | PRORT000290 | 6.64e-05 | Protein ratios | Pancreatic epithelium | 47 | 0 | 4 | 7 | |
| 4954 | ADM levels | PROLV000051 | 6.62e-05 | Protein levels | B / plasma cell | 52 | 1 | 6 | 13 | |
| 4955 | REN levels | PROLV001723 | 6.62e-05 | Protein levels | Neural / glial | 2 | 0 | 3 | 8 | |
| 4956 | PLXNA4/SPRY2 ratio | PRORT001685 | 6.54e-05 | Protein ratios | Hepatocyte | 22 | 5 | 11 | 23 | |
| 4957 | CNST/DOK2 ratio | PRORT000682 | 6.34e-05 | Protein ratios | Muscle / cardiac | 0 | 3 | 10 | 15 | |
| 4958 | Hypothyroidism, secondary | ENDOC000015 | 6.27e-05 | Endocrine | B / plasma cell | 0 | 2 | 11 | 20 | |
| 4959 | CDSN/NECTIN4 ratio | PRORT000584 | 6.25e-05 | Protein ratios | Cutaneous epithelium | 16 | 1 | 7 | 12 | |
| 4960 | CASP8/PPP3R1 ratio | PRORT000322 | 6.17e-05 | Protein ratios | Lymphocyte | 5 | 1 | 8 | 25 | |
| 4961 | WASF1 levels | PROLV002185 | 6.15e-05 | Protein levels | Myeloid | 2 | 1 | 1 | 7 | |
| 4962 | SERPINC1 levels | PROLV001828 | 6.08e-05 | Protein levels | Hepatocyte | 51 | 1 | 7 | 16 | |
| 4963 | Medical conditions, allergy etc, none | MISCL000026 | 5.95e-05 | Miscellaneous | Lymphocyte | 251 | 2 | 12 | 15 | |
| 4964 | CRTAM levels | PROLV000530 | 5.95e-05 | Protein levels | Lymphocyte | 122 | 2 | 13 | 20 | |
| 4965 | KLK8/NECTIN4 ratio | PRORT001412 | 5.85e-05 | Protein ratios | Cutaneous epithelium | 43 | 0 | 13 | 9 | |
| 4966 | DNMBP/PTPN1 ratio | PRORT000931 | 5.78e-05 | Protein ratios | Myeloid | 8 | 5 | 12 | 20 | |
| 4967 | FCRL5/TNFRSF13B ratio | PRORT001136 | 5.78e-05 | Protein ratios | B / plasma cell | 59 | 4 | 15 | 23 | |
| 4968 | Lymphatic disorder | HEMAT000020 | 5.73e-05 | Hematologic | Myeloid | 0 | 1 | 7 | 9 | |
| 4969 | GNLY levels | PROLV000905 | 5.68e-05 | Protein levels | Lymphocyte | 91 | 2 | 14 | 32 | |
| 4970 | Acute appendicitis | GASTR000009 | 5.55e-05 | Gastrointestinal | Myeloid | 28 | 1 | 2 | 7 | |
| 4971 | Pneumonopathy | RESPI000016 | 5.50e-05 | Respiratory | Pancreatic epithelium | 0 | 0 | 5 | 13 | |
| 4972 | F11R/PARK7 ratio | PRORT001072 | 5.50e-05 | Protein ratios | Hepatocyte | 0 | 1 | 7 | 26 | |
| 4973 | CKMT1A or CKMT1B levels | PROLV000442 | 5.48e-05 | Protein levels | Gastrointestinal epithelium | 59 | 0 | 10 | 7 | |
| 4974 | AZU1/RNASE3 ratio | PRORT000186 | 5.43e-05 | Protein ratios | Myeloid | 1 | 2 | 4 | 11 | |
| 4975 | METAP2/RILP ratio | PRORT001525 | 5.42e-05 | Protein ratios | Myeloid | 0 | 3 | 11 | 18 | |
| 4976 | FCRL6 levels | PROLV000787 | 5.36e-05 | Protein levels | Lymphocyte | 109 | 2 | 11 | 30 | |
| 4977 | CD74/DLL1 ratio | PRORT000502 | 5.36e-05 | Protein ratios | Vascular | 48 | 2 | 13 | 37 | |
| 4978 | BCL2L11 levels | PROLV000187 | 5.31e-05 | Protein levels | Myeloid | 90 | 2 | 7 | 17 | |
| 4979 | ORM1 levels | PROLV001473 | 5.19e-05 | Protein levels | Myeloid | 16 | 1 | 9 | 12 | |
| 4980 | CC2D1A/STAMBP ratio | PRORT000328 | 5.12e-05 | Protein ratios | Lymphocyte | 1 | 1 | 15 | 21 | |
| 4981 | HRG levels | PROLV000988 | 5.11e-05 | Protein levels | Neural / glial | 68 | 4 | 12 | 26 | |
| 4982 | CRADD/EDAR ratio | PRORT000743 | 5.09e-05 | Protein ratios | Myeloid | 37 | 4 | 5 | 13 | |
| 4983 | CD300LF levels | PROLV000332 | 5.07e-05 | Protein levels | Myeloid | 40 | 2 | 8 | 17 | |
| 4984 | GNE levels | PROLV000904 | 5.01e-05 | Protein levels | Myeloid | 3 | 2 | 4 | 11 | |
| 4985 | Allergic disease | IMMUN000003 | 4.98e-05 | Immunologic | Lymphocyte | 228 | 2 | 12 | 17 | |
| 4986 | DOK2 levels | PROLV000642 | 4.95e-05 | Protein levels | Platelet | 24 | 4 | 9 | 11 | |
| 4987 | KIR2DL2 levels | PROLV001141 | 4.94e-05 | Protein levels | Lymphocyte | 166 | 2 | 14 | 29 | |
| 4988 | FGF2 levels | PROLV000794 | 4.92e-05 | Protein levels | Adipose | 20 | 2 | 4 | 16 | |
| 4989 | POSTN levels | PROLV001603 | 4.91e-05 | Protein levels | Adipose | 40 | 1 | 5 | 14 | |
| 4990 | SCGN levels | PROLV001789 | 4.90e-05 | Protein levels | Gastrointestinal epithelium | 12 | 0 | 6 | 12 | |
| 4991 | Severe mental illness | PSYCH000017 | 4.90e-05 | Psychiatric | Neural / glial | 0 | 4 | 8 | 10 | |
| 4992 | CRYGD levels | PROLV000534 | 4.89e-05 | Protein levels | Hematopoietic progenitor | 17 | 1 | 5 | 20 | |
| 4993 | Skin keratoses, seborrhoeic | DERMA000022 | 4.88e-05 | Dermatologic | Hepatocyte | 13 | 1 | 12 | 26 | |
| 4994 | FLT4/KDR ratio | PRORT001167 | 4.87e-05 | Protein ratios | Vascular | 28 | 1 | 7 | 21 | |
| 4995 | AARSD1/PIK3AP1 ratio | PRORT000001 | 4.84e-05 | Protein ratios | Hematopoietic progenitor | 2 | 1 | 2 | 3 | |
| 4996 | HGF/MMP9 ratio | PRORT001283 | 4.78e-05 | Protein ratios | Hepatocyte | 20 | 4 | 13 | 28 | |
| 4997 | Skin elastin | DERMA000042 | 4.72e-05 | Dermatologic | Neural / glial | 0 | 4 | 5 | 19 | |
| 4998 | CA2/UBAC1 ratio | PRORT000279 | 4.59e-05 | Protein ratios | Muscle / cardiac | 0 | 2 | 7 | 10 | |
| 4999 | HLA-E levels | PROLV000976 | 4.49e-05 | Protein levels | Stromal / connective | 104 | 1 | 7 | 30 | |
| 5000 | C1QL2 levels | PROLV000223 | 4.44e-05 | Protein levels | Vascular | 43 | 2 | 7 | 24 |